triazoles has been researched along with Mucormycosis in 267 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.37) | 18.7374 |
| 1990's | 2 (0.75) | 18.2507 |
| 2000's | 64 (23.97) | 29.6817 |
| 2010's | 163 (61.05) | 24.3611 |
| 2020's | 37 (13.86) | 2.80 |
| Authors | Studies |
|---|---|
| Kurakado, S; Matsumoto, Y; Sugita, T | 1 |
| Chen, J; Dang, YC; Kong, QT; Liu, F; Sang, H; Yuan, F | 1 |
| Dubowik, M; Duda, M; Kołaczkowska, M; Lango, R; Lango-Maziarz, A; Siondalski, P | 1 |
| Clark, NM; Croos-Dabrera, R; Fisher, CE; Garcia-Diaz, J; Greenberg, RN; Kontoyiannis, DP; Kovanda, L; Miceli, MH; Nguyen, MH; Ostrosky-Zeichner, L; Spec, A; Thompson, GR; Young, JH | 1 |
| Chakrabarti, A; Patel, A; Patel, K; Shah, K | 1 |
| Buil, JB; den Dekker, BM; Festen, B; Heusinkveld, M; Melchers, M; Mooren, ERM; Schellaars, R; van Binsbergen, AL; van Bree, SHW; van Zanten, ARH; Verweij, PE | 1 |
| Chakraborty, S; Joe, G; Soman, R | 1 |
| Alali, M; Balsara, K; Barros, KL; Budnick, HC; Khaitan, A; Schulte, RR; Streicher, DA | 1 |
| Lee, SC; Smith, C | 1 |
| Akashi, K; Izumikawa, K; Kakeya, H; Kamei, K; Kanda, Y; Kimura, SI; Kishida, M; Kohno, S; Matsuda, M; Miyazaki, T; Miyazaki, Y; Mukae, H; Niki, Y; Ogawa, K; Okada, F; Suzuki, J; Takazono, T; Taniguchi, S; Tateda, K; Yoshida, M | 1 |
| Aguado, JM; Bodro, M; Carratalà, J; Cordero, E; Fariñas, MDC; Fernández-Ruiz, M; Fortún, J; Goikoetxea, J; Gutiérrez Martín, I; Illaro, A; López-Viñau, T; Moreno, A; Muñoz, P; Ramos-Martínez, A; Rodriguez-Álvarez, R; Ruiz-Ruigómez, M; Sabé, N; Salto-Alejandre, S; Valerio, M; Vidal, E | 1 |
| Feng, S; Shen, Y; Zhang, T | 1 |
| Denis, B; Madelaine, I; Pieragostini, R; Sauvageon, H; Touratier, S; Xhaard, A | 1 |
| Barać, A; Benítez-Peñuela, MÁ; Cheng, MP; Cornely, OA; Desoubeaux, G; Falces-Romero, I; García-Vidal, C; Heinz, WJ; Herbrecht, R; Hoenigl, M; Ingram, P; Iqbal, N; Klimko, N; Klyasova, G; Koehler, P; Krause, R; Mehta, SR; Mellinghoff, SC; Ostermann, H; Penack, O; Ráčil, Z; Rodríguez, JY; Salmanton-García, J; Schalk, E; Seidel, D; Sheppard, DC; Vehreschild, JJ; Vehreschild, MJGT; Willinger, B; Wisplinghoff, H | 1 |
| Benesch, M; Egger, M; Flaschberger, S; Gorkiewicz, G; Karastaneva, A; Kohlmaier, B; Lackner, H; Marterer, R; Seidel, M; Sperl, D; Strenger, V; Trobisch, A; Urban, C | 1 |
| Haque, H; Kumar, S; Nettboy, S | 1 |
| Gupta, N; Soneja, M | 1 |
| Fernandez, E; Makar, G; Perz, A; Rafferty, W; Weinstock, J | 1 |
| Demmler-Harrison, GJ; Dinu, D; Fatemizadeh, R; Rodman, E | 1 |
| Ashkenazi-Hoffnung, L; Ben-Ami, R; Bilavsky, E; Fischer, S; Grisaru, G; Levy, I; Nahum, E; Novikov, A; Sadot, E; Scheuerman, O | 1 |
| Ai Ling, T; Anindita, S; Chun, AC; Fong, R; Liang En, W; Seow Yen, T; Sze Hwa, T; Yen Ee, T | 1 |
| Engesser, J; Fleischer, V; Harpf, V; Lackner, M; Lass-Flörl, C; Maier, H; Meinitzer, A; Rambach, G; Speth, C | 1 |
| Ding, XL; Du, J; Li, HM | 1 |
| Chegini, Z; Didehdar, M; Khoshbayan, A; Rajaeih, S; Salehi, M; Shariati, A | 1 |
| Azanza, JR; Grau, S; López-Gómez, V; López-Ibáñez de Aldecoa, A; Peral, C; Rebollo, P; Vázquez, L | 1 |
| Steinbach, WJ | 1 |
| Baird, R; Campbell, K; Crawford, LC; Davidson, N; Davies, J; Foroughi, F; Kidd, SE; Lynar, S; Meumann, EM; Tayal, V | 1 |
| Auger, C; Durà-Miralles, X; Escolà-Vergé, L; Fernández-Hidalgo, N; Lung, M; Martín-Gómez, MT; Martínez-Ricarte, F; Moreno, D | 1 |
| Azar, MM; Pischel, L; Ringer, M | 1 |
| Chen, X; Guo, C; Liang, Y; Liu, F; Wang, J; Yang, J | 1 |
| Ahmadikia, K; Alijani, N; Badali, H; Getso, MI; Hashemi, SJ; Khodavaisy, S; Kord, M; Mirhendi, H; Mohammadi Ardehali, M; Rezaie, S; Roilides, E; Salehi, M; Tabari, A | 1 |
| Adeyemi, OA; Backous, CA; Coomes, DS; Logan, RL | 1 |
| Badali, H; Dadashzadeh, M; Diba, K; Fakhim, H; Kurzai, O; Mahdi, D; Nasri, E; Vaezi, A; Walther, G | 1 |
| Mammen, MD; Rupa, V; Sahni, RD; Varghese, GM | 1 |
| Durand, ML; Kitt, TM; Marty, FM; Song, Y | 1 |
| Abdollahi, A; Ahmadikia, K; Alijani, N; Barac, A; Jafari, R; Khodavaisy, S; Mehrparvar, G; Pakdel, F; Rajaeih, S; Rezaie, Y; Salehi, M; Tabari, A | 1 |
| Gebremariam, T; Gu, Y; Ibrahim, AS; Kitt, TM; Singh, S | 1 |
| Mhatre, S; Patravale, V | 1 |
| Bassetti, M; Bouza, E | 1 |
| Denis, J; Herbrecht, R; Ledoux, MP; Toussaint, E | 1 |
| Chen, J; Giovanni, G; Liu, G; Qiao, J; Song, Y; Wu, J; Yang, H | 1 |
| Anand, S; Dixit, A; Gambhir, R; Sahota, R | 1 |
| Hennessey, DB; Kinnear, N; Pilch, WT | 1 |
| Alkhazraji, S; Filler, SG; Garvey, EP; Gebremariam, T; Hoekstra, WJ; Ibrahim, AS; Lin, L; Patterson, TF; Schotzinger, RJ; Wiederhold, NP | 1 |
| Wilby, KJ | 1 |
| Custer, P; Kelly Keating, M; Lockhart, SR; Lysen, C; Orscheln, R; Reich, P; Shute, T | 1 |
| Aghili, SR; Ghasemi, M; Gholinejad Ghadi, N; Haghani, I; Nikkhah, M; Seifi, Z; Shokohi, T; Vahedi Larijani, L | 1 |
| Denis, J; Herbrecht, R; Ledoux, MP; Nivoix, Y | 1 |
| Chen, C; Cornely, OA; Croos-Dabrera, R; Engelhardt, M; Heep, M; Lademacher, C; Maher, R; Marty, FM; Mullane, KM; Ostrosky-Zeichner, L; Perfect, JR | 1 |
| Alfano, G; Assirati, G; Ballarin, R; Cappelli, G; Codeluppi, M; Di Benedetto, F; Fontana, F; Francesca, D; Franceschini, E; Guaraldi, G; Magistri, P; Mussini, C; Rossi, G; Tarantino, G | 1 |
| Cornely, OA; Croos-Dabrera, R; Giladi, M; Lademacher, C; Lu, Q; Maher, RM; Marty, FM; Mullane, KM; Oren, I; Ostrosky-Zeichner, L; Perfect, JR; Rahav, G; Schmitt-Hoffmann, AH | 1 |
| McCarthy, MW; Moriyama, B; Petraitiene, R; Petraitis, V; Walsh, TJ | 1 |
| Buchheidt, D; Hoenigl, M; Jenks, JD; Krause, R; Prattes, J; Salzer, HJ | 1 |
| Abgueguen, P; Danneels, P; Dib, M; Dubée, V; Klosek, M; Le Govic, Y; Mahieu, R; Rabier, V | 1 |
| Bagshaw, E; Blackney, M; Enoch, DA; Kuessner, D; Posthumus, J | 1 |
| Bao, Y; Li, F; Li, L; Liang, J; Wang, Y; Xu, J; Zhu, L; Zhu, M | 1 |
| Binder, U; Grässle, D; Hörtnagl, C; Lackner, M; Lass-Flörl, C; Maurer, E; Moser, P; Naschberger, V; Segal, E; Semis, M | 1 |
| Barg, AA; Bartuv, M; Greenberg, G; Keller, N; Malkiel, S; Toren, A | 1 |
| Barnes, AMT; Hansen, GT; Huebner, B; Nelson, S; Sabin, AP; Thielen, BK; Wesenberg, E | 1 |
| Andersen, LO; Arendrup, MC; Hare, RK; Irga-Jaworska, N; Jaworski, R; Jensen, HE; Malecka, A; Nielsen, HV; Pomorska, A; Radon-Proskura, J | 1 |
| Fotiou, E; Gkegkes, ID; Karetsou, A; Konstantara, F; Kotrogiannis, I; Papazacharias, C; Paraskevopoulos, IA; Stamopoulou, S; Tsiplakou, S | 1 |
| Chang, H; Huang, Y; Wang, PN | 1 |
| Agarwal, I; Arumugam, V; Duhli, N; Mathew, G; Murugesan, S | 1 |
| Gupta, KL; Kohli, HS; Ramachandran, R; Sethi, J | 1 |
| Cherian, S; Fernandes, D; George, P; Nayar, S; Pawar, B; Thomas, S | 1 |
| Abdolalizadeh, P; Ghazizadeh, M; Hadi, Y; Karimi, N; Kashkouli, MB; Oghazian, M | 1 |
| Amzallag-Bellenger, E; Bruno, B; Cornu, M; Dubos, F; François, N; Lanternier, F; Loridant, S; Mazingue, F; Navarin, P; Sendid, B | 1 |
| Deeren, D; Vulsteke, JB | 1 |
| Chen, SC; Jeong, W; Keighley, C; Kong, DCM; Lee, WL; Slavin, MA; Wolfe, R | 1 |
| Bagshaw, E; Floros, L; Kuessner, D; Posthumus, J; Sjölin, J | 1 |
| Chen, H; Chen, X; Liu, H; Qiu, S; Shen, Z; Wang, W; Yang, L; Zhang, Q | 1 |
| Dannaoui, E; Felske-Zech, H; Schwarz, P; Schwarz, PV | 1 |
| Ahmed, G; Ahmed, N; El-Mahallawy, H; Hafez, H; Hassanain, O; Khedr, R; Madney, Y; Taha, H; Youssef, A | 1 |
| Ally, MT; Gupta, V; Jenkins, IH | 1 |
| Bruneel, F; de Roquetaillade, C; Hamon, M; Paktoris, H | 1 |
| Alastruey-Izquierdo, A; de Hoog, S; Kurzai, O; Voigt, K; Wagner, L; Walther, G | 1 |
| Cornely, OA; Koehler, P; Reimer, R; Schömig-Markiefka, B; Wahba, R | 1 |
| Cadelis, G | 1 |
| Campos, VF; Cruz, LR; Danilow, MZ; dos Santos, VM; Paixão, GT; Ribeiro, EF | 1 |
| Almannai, M; Estrada, B; Imran, H; Siddiqui, AH | 1 |
| Lanternier, F; Lortholary, O; Pilmis, B | 1 |
| Li, R; Yu, J; Zhang, S | 1 |
| Filler, SG; French, SW; Gebremariam, T; Ibrahim, AS; Lee, H; Luo, G; Patterson, TF; Wiederhold, NP | 1 |
| Busca, A; Caira, M; Candoni, A; Cesaro, S; Cornely, OA; Gasbarrino, C; Girmenia, C; Heinz, WJ; Herbrecht, R; Lass-Flörl, C; Nosari, A; Pagano, L; Potenza, L; Racil, Z; Rickerts, V; Sheppard, DC; Simon, A; Ullmann, AJ; Valentini, CG; Vehreschild, JJ; Vehreschild, MJ | 1 |
| Azari, AA; Ghoghawala, SY; Kanavi, MR; Lee, V; Nehls, S; Potter, HD | 1 |
| Alffenaar, JW; Greijdanus, B; Kosterink, JG; Span, LF; Uges, DR; van der Elst, KC; van der Werf, TS; van Hateren, K; Vermeulen, KM | 1 |
| Cho, BS; Choi, JH; Choi, SM; Kim, HJ; Kim, SH; Kwon, JC; Lee, DG; Lee, HJ; Lee, JW; Lee, S; Min, CK; Min, WS; Park, SH; Yoo, JH | 1 |
| Labbadia, F; Sanchez-Salinas, A | 1 |
| Leroux, S; Ullmann, AJ | 1 |
| Ervens, J; Ghannoum, M; Graf, B; Schwartz, S | 1 |
| Fang, BM; Fang, F; Pan, MM; Sun, TY; Xu, XM; Yang, YM; Zhong, XF | 1 |
| Gagne, LS; Gilmore, ET; Hammond, SP; Joyce, AC; Marty, FM; Peixoto, D; Soiffer, RJ | 1 |
| Edwards, JE; Gebremariam, T; Ibrahim, AS; Kovanda, L; Lee, H; Luo, G | 1 |
| Conner, JR; Jacobson, FL; Juan, YH; Khandelwal, A; Lin, YC; Saboo, SS | 1 |
| Breitenstein, S; Clavien, PA; Dutkowski, P; Flury, S; Kaiser, P; Maggio, EM; Misselwitz, B; Mueller, NJ; Müllhaupt, B; Pfammatter, T; Schneider, PM | 1 |
| Cornely, OA; Koehler, P; Markiefka, B; Tacke, D | 1 |
| Klimova, K; Padilla Suárez, C; Peláez, T; Salcedo Plaza, M | 1 |
| Knoll, BM | 1 |
| Fouant, MM; Katragkou, A; Kovanda, LL; McCarthy, M; Meletiadis, J; Moradi, PW; Petraitiene, R; Petraitis, V; Roilides, E; Strauss, GE; Walsh, TJ | 1 |
| Albert, ND; Kontoyiannis, DP; Lewis, RE | 1 |
| Banke, IJ; Harrasser, N; Hauschild, M; Lenze, U; Peschel, C; Prodinger, PM; Ringshausen, I; Toepfer, A; Verbeek, M; von Eisenhart-Rothe, R | 1 |
| Chowdhary, A; Dolatabadi, S; Hagen, F; Kathuria, S; Meis, JF; Sharma, B; Singh, PK | 1 |
| Bouquié, R; Gaultier-Lintia, A; Giral, M; Le Pape, P; Morio, F; Sagan, C; Talarmin, JP; Ville, S | 1 |
| Pajpani, M; Webb, R | 1 |
| Alfaya Muñoz, L; Avendaño Cantos, EM; Celis Sánchez, J; Mesa Varona, D; Romero Moraleda, L | 1 |
| Chakrabarti, A; Chowdhary, A; Cordoba, S; Dannaoui, E; Dufresne, P; Espinel-Ingroff, A; Fothergill, A; Ghannoum, M; Gonzalez, GM; Guarro, J; Kidd, S; Lass-Flörl, C; Meis, JF; Pelaez, T; Tortorano, AM; Turnidge, J | 1 |
| Alanio, A; Benyamina, M; Chaouat, M; Denis, B; Ferry, A; Legrand, M; Maurel, V; Mebazaa, A; Mimoun, M; Padoin, C; Ressaire, Q; Soussi, S | 1 |
| Marr, K; Ostrander, D; Shoham, S | 1 |
| McCormack, PL | 1 |
| Allende, BL; Allende, C; Bergallo, C; Marangoni, LD; Martinatto, C; Minoldo, E; Paoletti, OA; Riera, F | 1 |
| Camargo, JF; Cho-Vega, JH; Yakoub, D | 1 |
| Kauffman, CA; Miceli, MH | 1 |
| Albert, ND; Bellanger, AP; Kontoyiannis, DP; Lewis, RE; Walsh, TJ | 1 |
| Aguilar, C; Alanio, A; Catherinot, E; Danion, F; DeWolf, S; Lanternier, F; Lortholary, O | 1 |
| Chowdhary, A; Hagen, F; Kathuria, S; Meis, JF; Singh, PK | 1 |
| Arendrup, MC; Jensen, RH; Meletiadis, J | 1 |
| Marx, KR; Nishimoto, AT; Rogers, PD; Rybak, JM | 1 |
| Al Mohajer, M; Beatty, N | 1 |
| Carlson, D; Mattioni, J; Moore, JE; Portnoy, JE; Sataloff, RT | 1 |
| Deyo, JC; Kozlowski, T; Lachiewicz, A; Nicolsen, N | 1 |
| Antachopoulos, C; Roilides, E | 1 |
| Alangaden, GJ; Brown, JM; Chetchotisakd, P; Cornely, OA; Engelhardt, M; Fredricks, DN; Heinz, WJ; Herbrecht, R; Ito, M; Jaruratanasirikul, S; Kanj, SS; Kaufhold, A; Klimko, N; Klyasova, G; Lee, M; Maertens, JA; Maher, RM; Marty, FM; Melinkeri, SR; Mullane, KM; Oren, I; Ostrosky-Zeichner, L; Pappas, PG; Perfect, JR; Ráčil, Z; Rahav, G; Santos, R; Sasse, C; Schwartz, S; Thompson, GR; Vehreschild, JJ; Vehreschild, MJGT; Young, JH; Zeiher, B | 1 |
| Hope, WW; Kovanda, LL; Maher, R | 1 |
| Akhtar, S; Bonate, P; Desai, AV; Hope, WW; Kovanda, LL; Lu, Q; Townsend, RW | 1 |
| Chitasombat, MN; Kontoyiannis, DP | 1 |
| Legendre, DP; Muzny, CA; Riley, TT; Swiatlo, E | 1 |
| Hu, H; Hu, Y; Huang, H; Jin, A; Luo, C; Luo, Y; Tan, Y; Wang, J; Wei, B | 1 |
| Benefield, RJ; Ditolla, K; Kim, JH | 1 |
| Bernardo, RM; Gurung, A; Jain, D; Malinis, MF | 1 |
| John, AO; Manesh, A; Mathew, B; Rupa, V; Varghese, GM; Varghese, L; Zachariah, A | 1 |
| Afif, C; Chamseddine, N; Choueiry, C; El Hachem, G; Saidy, G | 1 |
| Scott, LJ; Shirley, M | 1 |
| Alqarihi, A; Azie, N; Edwards, JE; Gebremariam, T; Ibrahim, AS; Uppuluri, P; Wiederhold, NP | 1 |
| Arendrup, MC; Frandsen, TL; Jensen, TSR; Juhler, M; Nygaard, U; von Buchvald, C | 1 |
| Burgess, MJ; Crescencio, JC; Kothari, A; Shalin, SC | 1 |
| Andrey, DO; Chalandon, Y; Emonet, S; Erard, V; Kaiser, L; van Delden, C | 1 |
| Ahmad, K; Beatty, N; Jaffer, F | 1 |
| Acuña Vassallo, JP; Alvarez Milan, L; Frey Gutierrez, ME; Martinez, GW; Trinajstic, EM | 1 |
| Bagshaw, E; Blackney, M; Cornely, OA; Escrig, C; Heimann, SM; Kuessner, D; Posthumus, J | 1 |
| Alkhazraji, S; Baldin, C; Gebremariam, T; Ibrahim, AS; Kovanda, L; Wiederhold, NP | 1 |
| Desai, AV; Engelhardt, M; Hope, WW; Kovanda, LL; Lademacher, C; Lu, Q; Maertens, J; Marty, FM | 1 |
| Garner, D; Machin, K | 1 |
| de La Tour, R; Lacroix, C; Lagrange-Xélot, M; Molina, JM; Schlemmer, F; Socié, G | 1 |
| Evans, AJ; Liles, WC; Page, AV; Snell, L | 1 |
| Johnson, EM; Sparkes, AH; Wray, JD | 1 |
| Guarro, J; Mariné, M; Pastor, FJ; Rodríguez, MM; Serena, C | 1 |
| Kishel, JJ; Sivik, J | 1 |
| Costantino, F; Di Biasi, C; Friederici, D; Notheis, G; Pasquino, AM; Tarani, L; Venditti, M; Wintergerst, U | 1 |
| Coombs, C; Cottrill, E; Gonis, G; Trotter, DJ | 1 |
| Edwards, J; Ibrahim, AS; Spellberg, B | 1 |
| Amador, R; Bertrán-Pasarell, J; Conde, A; González-Ramos, MM; Guiot, H; Santana, J; Soto, R | 1 |
| Aebi, C; Berger, S; Diepold, M; Duppenthaler, A; Lüer, S; Mühlethaler, K; von Gunten, M; Wolf, R | 1 |
| de Mol, P; Meis, JF | 1 |
| Alp, S; Arikan, S; Hascelik, G; McNicholas, P; Sancak, B | 1 |
| Canivet, JL; De Pasqual, A; Deprez, M; Frère, P; Ghaye, B; Hayette, MP; Kaschten, B; Martin, D; Radermecker, M | 1 |
| Dan, M; Marom, T; Roth, Y; Watad, W | 1 |
| Moreno López, E; Rodríguez Losada, M; Roibal, MA; Sanduende Otero, Y | 1 |
| Kida, M | 1 |
| Andes, D; Anglim, A; Bonilla, H; Ibrahim, AS; Mathisen, GE; Perez, M; Spellberg, B; Walsh, TJ | 1 |
| Edwards, J; Ibrahim, AS; Kontoyiannis, DP; Spellberg, B; Walsh, TJ | 1 |
| Adegbola, SO; Banerjee, A; Mulcahy, MP | 1 |
| Mezhir, JJ; Mullane, KM; Pai, RK; Roggin, KK; Satoskar, R; Zarling, J | 1 |
| Baraboutis, IG; Davis, GJ; Howard, DS; Lawson, A; Lekakis, LJ; Monohan, G; Prante, J; Ribes, J; Skoutelis, AT | 1 |
| Chantzis, A; Daikos, GL; Polychronopoulou, H; Prodromou, P; Skiada, A; Tofas, P; Vrana, L | 1 |
| Alastruey-Izquierdo, A; Castelli, MV; Cuesta, I; Mellado, E; Monzón, A; Rodríguez-Tudela, JL; Zaragoza, O | 1 |
| Kontoyiannis, DP; Lewis, RE; Pongas, GN; Samonis, G | 1 |
| Calvo, E; Guarro, J; Pastor, FJ; Rodríguez, MM; Salas, V; Sutton, DA | 1 |
| Bier, H; Chaker, A; Cornely, O; Engers, R; Greve, J; Hoffmann, TK; Scheckenbach, K; Schipper, J; Wagenmann, M | 1 |
| Bonadona, A; Faure, O; Hamidfar, R; Karkas, A; Mescam, L; Minet, C; Pison, C; Saint-Raymond, C; Salameire, D; Schwebel, C; Tabah, A; Timsit, JF | 1 |
| Bug, G; Heinz, WJ; Mousset, S; Rickerts, V; Tintelnot, K | 1 |
| Friedstrom, S; Gersch, K; Nebel, C; Rodersheimer, LR; Smith, JM | 1 |
| Cornely, OA | 1 |
| Corradini, N; Dannaoui, E; Gay-Andrieu, F; Hoinard, D; Lortholary, O; Méchinaud, F; Roux, BG | 1 |
| Ambrosioni, J; Garbino, J; Gumy-Pause, F; Myers, C | 1 |
| Awan, F; Hamadani, M; Villalona-Calero, MA | 1 |
| Calvo, E; Fothergill, AW; Guarro, J; Pastor, FJ; Rinaldi, MG; Rodríguez, MM; Salas, V; Sutton, DA | 1 |
| Chalandon, Y; Garbino, J; Lamoth, F; Lebeau, O; Passweg, J; Robert, J; Van Delden, C | 1 |
| Jain, S; Kapoor, G | 1 |
| Cadena, JA; Owens, AD; Palacio-Bedoya, F; Patterson, TF; Sutton, DA; Thompson, GR | 1 |
| Butler, C; Clarke, P; Habibi, M; Howard, D; Kulendra, K | 1 |
| Bernardin, G; Burel-Vandenbos, F; Dunais, B; Gari-Toussaint, M; Guidicelli, S; Hyvernat, H | 1 |
| Bijleveld, Y; Brüggemann, RJ; de Boer, M; Kuijpers, TW; Oomen, MW; Pajkrt, D; van den Berg, JM; Wildenbeest, JG | 1 |
| Friedland, JS; Ind, PW; Nogueira, EL; Salama, AD | 1 |
| Alvarez, E; Cano, J; Fothergill, AW; Guarro, J; Rinaldi, MG; Salas, V; Stchigel, AM; Sutton, DA | 1 |
| Lagrou, K; Maertens, J; Meersseman, W; Saegeman, V; Spriet, I; Verbeken, E | 1 |
| Guarro, J; Mayayo, E; Pastor, FJ; Pujol, I; Ruíz-Cendoya, M; Sutton, DA | 1 |
| Curto, CL; Danvin, JB; Dessi, P; Mimouni, O; Thomassin, JM | 1 |
| Alvarez, E; Cano, JF; Dromer, F; Fothergill, AW; Garcia-Hermoso, D; Guarro, J; Hoinard, D; Rinaldi, MG; Stchigel, AM; Sutton, DA | 1 |
| Ho, MW; Lin, HC; Lu, MY; Peng, CT; Weng, TF; Wu, KH | 1 |
| Baietto, L; Bertucci, R; Calcagno, A; D'Avolio, A; De Rosa, FG; Di Perri, G; Libanore, V; Tettoni, MC | 1 |
| Bajwa, RP; Fung, B; Garee, A; Gross, TG; Pietryga, D; Rawlinson, NJ; Skeens, M; Soni, S; Termuhlen, AM | 1 |
| Aiba, K; Dobashi, N; Kasama, K; Katsube, A; Machishima, T; Minami, J; Nishiwaki, K; Ogasawara, Y; Saito, T; Shimada, T; Sugiyama, K; Takahara, S; Takei, Y; Usui, N; Yahagi, Y; Yamaguchi, Y; Yano, S; Yokoyama, H | 1 |
| Amir, J; Ashkenazi-Hoffnung, L; Avitzur, Y; Bilavsky, E | 1 |
| Kempker, J; Kempker, R; Sheth, A | 1 |
| Avery, S; Chang, CC; Grigoriadis, G; Morrissey, O; Patil, S; Spencer, A; Walker, P | 1 |
| Khera, S; Rustagi, T; Uy, EM | 1 |
| Barbui, A; Busca, A; De Rosa, FG; Falda, M; Limerutti, G; Locatelli, F | 1 |
| Aliyu, SH; Enoch, DA; Karas, JA; Lewis, SJ; Sule, O | 1 |
| Agrawal, S; Bali, R; Bhagol, A; Sen, R; Sharma, B; Singh, V | 1 |
| DiBartolo, MA; Kelley, PS | 1 |
| Arda, B; Ceylan, N; Erdem, A; Işıkgöz Taşbakan, M; Metin, DY; Midilli, R; Pullukçu, H; Sipahi, OR; Taşbakan, MS; Ulusoy, S; Yamazhan, T | 1 |
| Brass, EP; Chin-Hong, PV; Fredricks, D; Ibrahim, AS; Kontoyiannis, DP; Morris, MI; Perfect, JR; Spellberg, B | 2 |
| Aronowitz, P; Tan, S | 1 |
| Gupta, N; Rodrigues, C; Shetty, A; Soman, R | 1 |
| Donnelly, JP; Lahav, M | 1 |
| Kontoyiannis, DP | 1 |
| Kontoyiannis, DP; Lewis, RE; Lortholary, O; Roilides, E; Spellberg, B; Walsh, TJ | 1 |
| Ibrahim, A; Kontoyiannis, DP; Lewis, RE; Lortholary, O; Petrikkos, G; Roilides, E; Spellberg, B; Walsh, TJ | 1 |
| Ibrahim, A; Kontoyiannis, DP; Lewis, RE; Lortholary, O; Lotholary, O; Petrikkos, G; Roilides, E; Roillides, E; Spellberg, B; Walsh, TJ | 1 |
| Alvarez, E; Calvo, E; Fothergill, AW; Guarro, J; Mayayo, E; Pastor, FJ; Rinaldi, MG; Salas, V; Sutton, DA | 1 |
| Alvarez, E; Calvo, E; Chander, J; Guarro, J; Mayayo, E; Pastor, FJ; Salas, V; Sutton, DA | 1 |
| Alvarez, E; Calvo, E; Dromer, F; Fothergill, A; García-Hermoso, D; Guarro, J; Mayayo, E; Pastor, FJ; Salas, V; Sutton, D | 1 |
| Ackermann, F; Charles, P; Honderlick, P; Kahn, JE; Lortholary, O | 1 |
| Chang, YT; Chen, CY; Chen, TC; Chen, YH; Huang, CH; Lai, CC; Lin, CY; Lin, SY; Lin, WR; Lu, PL; Tsai, KB | 1 |
| Birtel, A; Cornely, OA; Farowski, F; Fätkenheuer, G; Kochanek, M; Liss, B; Sieniawski, M; Steinbach, A; Vehreschild, JJ; Vehreschild, MJ; Wahlers, K | 1 |
| AlMuzrkchi, A; Falamarzi, A; Guarro, J; Taj-Aldeen, SJ | 1 |
| Bell, W; Chaaban, MR; Woodworth, BA | 1 |
| Abboud, CS; Baía, CE; Bergamasco, MD; Lallée, MP; Mies, S; Pereira, OI; Zamorano, MM; Zan, AS | 1 |
| Abu El-Naaj, I; Leiser, Y; Peled, M; Wolff, A | 1 |
| Fernandez, JF; Maselli, DJ; Restrepo, MI; Simpson, T | 1 |
| Alhede, M; Bjarnsholt, T; Braendstrup, P; Clasen-Linde, E; Eickhardt, S; Høiby, N; Jensen, KE; Moser, C; Vindeløv, L | 1 |
| Albert, N; Ben-Ami, R; Best, L; Kontoyiannis, DP; Lewis, RE; Walsh, TJ | 1 |
| Chan, TM; Choy, CB; Kwan, LP; Suen, WS; Yap, DY | 1 |
| Arabia, FA; Blair, JE; Kusne, S; Scott, RL; Steidley, DE; Vikram, HR; Webb, BJ | 1 |
| Daugelaviciene, V; Kleinotiene, G; Machaczka, M; Posiunas, G; Raistenskis, J; Stankeviciene, S; Zurauskas, E | 1 |
| Stevens, DA | 1 |
| Arango, M; Fernández, D; Restrepo, A; Tobón, AM | 1 |
| Miller, JL; Perfect, JR; Schell, WA; Steinbach, WJ | 1 |
| Candoni, A; Corvatta, L; D'Antonio, D; Del Favero, A; Fianchi, L; Girmenia, C; Martino, P; Nosari, A; Offidani, M; Pagano, L; Picardi, M | 1 |
| Hahn, U; Küker, W; Lengerke, A | 1 |
| Mattner, F; Strueber, M; Weissbrodt, H | 1 |
| Blin, N; Gaillard, F; Harousseau, JL; Milpied, N; Moreau, P; Morin, O; Morineau, N | 1 |
| Chevallier, P; Dubruille, V; Guillaume, T; Harousseau, JL; Mahé, B; Méchinaud, F; Milpied, N; Moreau, P; Morin, O; Morineau, N; Vigouroux, S | 1 |
| Oren, I | 1 |
| Besnard, M; Brugière, O; Dauriat, G; Dupont, B; Fournier, M; Groussard, O; Lesèche, G; Mal, H; Marrash-Chalha, R | 2 |
| Amini, K; Garbino, J; Lew, D; Puppo, M; Richter, M; Uçkay, I | 1 |
| Bethge, WA; Einsele, H; Hebart, H; Horger, M; Kanz, L; Kröber, SM; Schmalzing, M; Schumacher, U; Stuhler, G | 1 |
| Akova, M; Sahin, GO | 1 |
| Cockerham, KP; Rutar, T | 1 |
| Colpaert, C; De Decker, K; Ieven, M; Jorens, PG; Van Poucke, S; Vogelaers, D; Wojciechowski, M | 1 |
| Atta, J; Bialek, R; Herrmann, S; Jacobi, V; Just-Nübling, G; Lambrecht, E; Rickerts, V | 1 |
| Belohradsky, BH; Costantino, F; Friederici, D; Jansson, A; Notheis, G; Reinhardt, D; Rosenecker, J; Schweinitz, DV; Seger, R; Tarani, L; Wintergerst, U | 1 |
| Edwards, JE; Ibrahim, A; Reed, C; Spellberg, B; Walot, I | 1 |
| Barchiesi, F; Fothergill, AW; Giannini, D; Pisa, E; Rinaldi, MG; Santinelli, A; Scalise, G; Spreghini, E | 1 |
| DeRemer, D; Fain, H; Farrow, S; Jillella, AP; Ustun, C | 1 |
| Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA | 1 |
| Senanayake, S | 1 |
| Harada, AS; Lau, W | 1 |
| Amedro, P; Blayac, JP; Cociglio, M; Eiden, C; Hillaire-Buys, D; Margueritte, G; Peyrière, H; Tichit, R | 1 |
| Durairaj, VD; Gelston, CD; Simoes, EA | 1 |
| Hosoki, T; Ikuta, K; Jimbo, J; Kohgo, Y; Nishimura, K; Sano, A; Sato, K; Shindo, M; Torimoto, Y | 1 |
| Chacko, B; David, VG; Deepti, AN; John, GT; Tamilarasi, V | 1 |
| Chen, S; Gilroy, N; Halliday, C; Kevin, P; Kok, J; Lee, OC; Novakovic, D | 1 |
| Edwards, JE; French, SW; Fu, Y; Gebermariam, T; Husseiny, MI; Ibrahim, AS; Lin, L; Schwartz, J; Skory, CD; Spellberg, BJ | 1 |
| Blijlevens, NM; Donnelly, JP; van der Velden, WJ; Verweij, PE; Warris, A | 1 |
| Clauss, H; Samuel, R | 1 |
| Block, CA; Cotter, JG; Kaneko, TM; Parsonnet, J; Sedlacek, M; Suriawinata, AA; Zuckerman, RA | 1 |
| Dojcinovic, I; Richter, M | 1 |
| Baldelli, F; Costantini, V; Giovenale, P; Gurdo, G; Lapalorcia, LM; Lignani, A; Pasticci, MB; Pitzurra, L; Terenzi, A; Verzini, F | 1 |
| Cuenca-Estrella, M; Dierich, MP; Lass-Flörl, C; Locher, M; Perkhofer, S; Rüchel, R; Würzner, R | 1 |
| Goldani, LZ; Sugar, AM | 1 |
| Bouza, E; Muñoz, P | 1 |
| Bocanegra, R; Graybill, JR; Loebenberg, D; Najvar, LK; Sun, QN | 1 |
| Fransen, J; Janssen, PA; Van Cutsem, J; Van Gerven, F | 1 |
50 review(s) available for triazoles and Mucormycosis
| Article | Year |
|---|---|
Current treatments against mucormycosis and future directions.
Topics: Amphotericin B; Antifungal Agents; Debridement; Humans; Lipids; Mucormycosis; Triazoles | 2022 |
Clinical research advances of isavuconazole in the treatment of invasive fungal diseases.
Topics: Antifungal Agents; Aspergillosis; Candidiasis, Invasive; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Triazoles | 2022 |
Epidemiology, clinical features, diagnosis and treatment of cerebral mucormycosis in diabetic patients: A systematic review of case reports and case series.
Topics: Amphotericin B; Antifungal Agents; Brain Diseases; Deoxycholic Acid; Diabetes Complications; Diabetes Mellitus; Drug Combinations; Humans; Mucormycosis; Risk Factors; Triazoles | 2020 |
Disseminated Saksenaea infection in an immunocompromised host associated with a good clinical outcome: a case report and review of the literature.
Topics: Aged; Amphotericin B; Antifungal Agents; Granulomatosis with Polyangiitis; Humans; Immunocompromised Host; Male; Mucormycosis; Northern Territory; Triazoles | 2020 |
The double-edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza-associated mucormycosis versus COVID-19 associated mucormycosis.
Topics: Adrenal Cortex Hormones; Adult; Amphotericin B; Antifungal Agents; COVID-19; Diabetes Complications; Female; Humans; Influenza, Human; Liposomes; Mucormycosis; Pneumonia, Viral; Triazoles | 2021 |
Invasive mould infections in the ICU setting: complexities and solutions.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; beta-Glucans; Critical Illness; Galactose; Humans; Immunocompromised Host; Intensive Care Units; Invasive Fungal Infections; Lung Diseases, Fungal; Mannans; Mucor; Mucormycosis; Nitriles; Opportunistic Infections; Pyridines; Respiratory System; Triazoles; Voriconazole | 2017 |
A Review of the Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole.
Topics: Antifungal Agents; Biological Availability; Drug Monitoring; Humans; Mucormycosis; Nitriles; Pyridines; Triazoles | 2018 |
Isavuconazole: A new broad-spectrum azole. Part 2: pharmacokinetics and clinical activity.
Topics: Animals; Antifungal Agents; Aspergillosis; Azoles; Candidemia; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation, Preclinical; Esterases; Humans; Invasive Fungal Infections; Mice; Mucormycosis; Nitriles; Pyridines; Triazoles | 2018 |
Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial.
Topics: Adult; Antifungal Agents; Fungi; Humans; Immunocompromised Host; Invasive Fungal Infections; Invasive Pulmonary Aspergillosis; Middle Aged; Mucormycosis; Mycoses; Nitriles; Pyridines; Randomized Controlled Trials as Topic; Rare Diseases; Renal Insufficiency; Triazoles | 2018 |
Gastric Mucormycosis in a Liver and Kidney Transplant Recipient: Case Report and Concise Review of Literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Humans; Immunocompromised Host; Kidney Transplantation; Liver Transplantation; Mucormycosis; Stomach Diseases; Triazoles | 2018 |
Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole.
Topics: Adult; Animals; Antifungal Agents; Aspergillosis; Drug Interactions; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Triazoles | 2018 |
Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy.
Topics: Animals; Antifungal Agents; Aspergillosis; Drug Design; Humans; Mucormycosis; Nitriles; Pyridines; Triazoles | 2018 |
Isavuconazole in a Successful Combination Treatment of Disseminated Mucormycosis in a Child with Acute Lymphoblastic Leukaemia and Generalized Haemochromatosis: A Case Report and Review of the Literature.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Cunninghamella; Debridement; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Hemochromatosis; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyridines; Treatment Outcome; Triazoles | 2019 |
Cutaneous Mucormycosis by Saksenaea vasiformis: An Unusual Case Report and Review of Literature.
Topics: Administration, Intravenous; Amphotericin B; Amputation, Surgical; Antifungal Agents; Debridement; Dermatomycoses; Female; Greece; Humans; Middle Aged; Mucorales; Mucormycosis; Thigh; Triazoles | 2019 |
Contemporary management and clinical outcomes of mucormycosis: A systematic review and meta-analysis of case reports.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Combined Modality Therapy; Disease Management; Drug Therapy, Combination; Female; Humans; Itraconazole; Male; Middle Aged; Mucormycosis; Surgical Procedures, Operative; Survival Analysis; Treatment Outcome; Triazoles; Young Adult | 2019 |
[Mucormycosis: therapeutic news].
Topics: Amphotericin B; Antifungal Agents; Debridement; Humans; Immunocompromised Host; Mucormycosis; Triazoles | 2013 |
Management and diagnostic guidelines for fungal diseases in infectious diseases and clinical microbiology: critical appraisal.
Topics: Antifungal Agents; Aspergillosis; Candidiasis, Invasive; Evidence-Based Medicine; Humans; Mucormycosis; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole | 2013 |
Our 2014 approach to mucormycosis.
Topics: Amphotericin B; Antifungal Agents; Debridement; Humans; Immunocompromised Host; Mucorales; Mucormycosis; Triazoles | 2014 |
Isavuconazonium: first global approval.
Topics: Animals; Aspergillosis; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Approval; Humans; Mucormycosis; Nitriles; Pyridines; Randomized Controlled Trials as Topic; Triazoles | 2015 |
[Mucormycosis. Clinical cases and update].
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Fatal Outcome; Female; Humans; Male; Middle Aged; Mucormycosis; Rifampin; Risk Factors; Triazoles; Young Adult | 2014 |
Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent.
Topics: Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Humans; Invasive Pulmonary Aspergillosis; Mucormycosis; Nitriles; Pyridines; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles | 2015 |
Mucormycosis: New Developments into a Persistently Devastating Infection.
Topics: Amphotericin B; Antifungal Agents; Combined Modality Therapy; Debridement; Hematopoietic Stem Cell Transplantation; Humans; Lung Diseases, Fungal; Mucorales; Mucormycosis; Nitriles; Pyridines; Triazoles | 2015 |
Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent.
Topics: Antifungal Agents; Aspergillosis; Candidemia; Candidiasis, Invasive; Humans; Mucormycosis; Nitriles; Pyridines; Triazoles | 2015 |
Salvage Treatment of Mucormycosis Post-Liver Transplant With Posaconazole During Sirolimus Maintenance Immunosuppression.
Topics: Antifungal Agents; Female; Humans; Immunosuppressive Agents; Liver Transplantation; Maintenance Chemotherapy; Middle Aged; Mucormycosis; Salvage Therapy; Sirolimus; Treatment Outcome; Triazoles | 2017 |
Isavuconazonium sulfate (Cresemba)--a new antifungal.
Topics: Antifungal Agents; Aspergillosis; Drug Interactions; Female; Fungi; Humans; Male; Mucormycosis; Mycoses; Nitriles; Pregnancy; Pyridines; Triazoles | 2016 |
Isavuconazonium sulfate: a new agent for the treatment of invasive aspergillosis and invasive mucormycosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Triazoles | 2016 |
Treatment of mucormycosis in transplant patients: role of surgery and of old and new antifungal agents.
Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; Humans; Mucorales; Mucormycosis; Nitriles; Opportunistic Infections; Pyridines; Salvage Therapy; Transplant Recipients; Triazoles | 2016 |
Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Debridement; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Mucorales; Mucormycosis; Nitriles; Pyridines; Triazoles; Virulence | 2016 |
Cunninghamella bertholletiae Infection in a HLA-Haploidentical Hematopoietic Stem Cell Transplant Recipient with Graft Failure: Case Report and Review of the Literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Cunninghamella; Fatal Outcome; Graft Rejection; Hematopoietic Stem Cell Transplantation; Humans; Male; Microbiological Techniques; Microscopy; Mucormycosis; Thorax; Tomography, X-Ray Computed; Transplant Recipients; Triazoles | 2016 |
Therapeutic Challenges of Hepatic Mucormycosis in Hematologic Malignancy: A Case Report and Review of the Literature.
Topics: Amphotericin B; Antifungal Agents; Chemotherapy, Adjuvant; Fatal Outcome; Female; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Liver Diseases; Middle Aged; Mucormycosis; Risk Factors; Treatment Failure; Treatment Outcome; Triazoles | 2016 |
Isavuconazole: A Review in Invasive Aspergillosis and Mucormycosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Case-Control Studies; Clinical Trials, Phase III as Topic; Humans; Mucormycosis; Nitriles; Pyridines; Triazoles | 2016 |
Primary cutaneous mucormycosis in a lung transplant recipient: case report and concise review of the literature.
Topics: Adult; Antifungal Agents; Debridement; Dermatomycoses; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lung Transplantation; Male; Mucormycosis; Postoperative Complications; Rhizopus; Silicosis; Triazoles | 2008 |
Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment.
Topics: Animals; Benzoates; Chelating Agents; Deferasirox; Deferiprone; Deferoxamine; Humans; Iron; Microbial Viability; Mucorales; Mucormycosis; Pyridones; Triazoles | 2008 |
Recent advances in the management of mucormycosis: from bench to bedside.
Topics: Amphotericin B; Antifungal Agents; Benzoates; Case Management; Clinical Trials as Topic; Deferasirox; Drug Therapy, Combination; Echinocandins; Humans; Immunologic Factors; Mucormycosis; Polyenes; Triazoles | 2009 |
Successful nonoperative management of gastrointestinal mucormycosis: novel therapy for invasive disease.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Gastrointestinal Diseases; Humans; Male; Middle Aged; Mucor; Mucormycosis; Treatment Outcome; Triazoles | 2009 |
Fatal rhizopus pneumonia in allogeneic stem cell transplant patients despite posaconazole prophylaxis: two cases and review of the literature.
Topics: Antifungal Agents; Chemoprevention; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mucormycosis; Pneumonia; Rhizopus; Transplantation, Homologous; Triazoles | 2009 |
Disseminated zygomycosis with involvement of the central nervous system.
Topics: Absidia; Amphotericin B; Antifungal Agents; Brain; Central Nervous System Fungal Infections; Child, Preschool; Humans; Liver; Lung; Male; Mucormycosis; Spinal Cord; Triazoles | 2009 |
In vitro activity of antifungals against Zygomycetes.
Topics: Amphotericin B; Antifungal Agents; Echinocandins; Humans; Microbial Sensitivity Tests; Mucorales; Mucormycosis; Pyrimidines; Triazoles; Voriconazole | 2009 |
Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices?
Topics: Antifungal Agents; Chemoprevention; Drug Resistance, Fungal; Humans; Immunocompromised Host; Mucorales; Mucormycosis; Pyrimidines; Transplantation; Triazoles; Voriconazole | 2009 |
Successful treatment of cutaneous zygomycosis with intravenous amphotericin B followed by oral posaconazole in a multivisceral transplant recipient.
Topics: Administration, Oral; Adolescent; Amphotericin B; Antifungal Agents; Cunninghamella; Dermatomycoses; Female; Humans; Injections, Intravenous; Mucormycosis; Transplants; Triazoles | 2010 |
Posaconazole for the treatment of mucormycosis.
Topics: Animals; Antifungal Agents; Disease Models, Animal; Female; Humans; Male; Mice; Microbial Sensitivity Tests; Mucorales; Mucormycosis; Treatment Outcome; Triazoles | 2011 |
Invasive mycoses: strategies for effective management.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Antifungal Agents; Antineoplastic Agents; Aspartate Aminotransferases; Aspergillosis; Bilirubin; Biomarkers; Drug Monitoring; Echinocandins; Female; Flucytosine; Humans; Immunocompromised Host; Leukemia; Liver; Liver Function Tests; Male; Middle Aged; Mucormycosis; Mycoses; Myelodysplastic Syndromes; Opportunistic Infections; Pneumonia; Risk Factors; Triazoles | 2012 |
A mucormycosis case in a cirrhotic patient successfully treated with posaconazole and review of published literature.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Diabetes Complications; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Mucorales; Mucormycosis; Triazoles | 2012 |
Mucormycosis treated with posaconazole: review of 96 case reports.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; Humans; Middle Aged; Mucormycosis; Salvage Therapy; Triazoles | 2013 |
Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide.
Topics: Administration, Topical; Anti-Bacterial Agents; Antifungal Agents; Biguanides; Caspofungin; Child, Preschool; Disinfectants; Echinocandins; Humans; Lipopeptides; Magnetic Resonance Imaging; Male; Mucormycosis; Osteomyelitis; Peptides; Peptides, Cyclic; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2003 |
Mucormycosis in hematologic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Encephalitis; Female; Fungemia; Hematologic Neoplasms; Humans; Immunocompromised Host; Italy; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Neutropenia; Retrospective Studies; Risk Factors; Sinusitis; Treatment Outcome; Triazoles | 2004 |
Two case reports: fatal Absidia corymbifera pulmonary tract infection in the first postoperative phase of a lung transplant patient receiving voriconazole prophylaxis, and transient bronchial Absidia corymbifera colonization in a lung transplant patient.
Topics: Absidia; Antibiotic Prophylaxis; Antifungal Agents; Bronchi; Fatal Outcome; Female; Humans; Lung Diseases, Fungal; Lung Transplantation; Male; Middle Aged; Mucormycosis; Pyrimidines; Triazoles; Voriconazole | 2004 |
Treatment of invasive infections due to rare or emerging yeasts and moulds.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; Humans; Immunocompromised Host; Mucormycosis; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole | 2006 |
Mucormycosis peritonitis: more than 2 years of disease-free follow-up after posaconazole salvage therapy after failure of liposomal amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Female; Humans; Kidney Failure, Chronic; Liposomes; Middle Aged; Mucormycosis; Peritoneal Dialysis; Peritonitis; Polycystic Kidney, Autosomal Dominant; Treatment Failure; Treatment Outcome; Triazoles | 2008 |
[Fungal infections in patients undergoing solid organ transplantation].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Celiac Artery; Cytomegalovirus Infections; Female; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppression Therapy; Incidence; Liver Transplantation; Male; Middle Aged; Mucormycosis; Mycoses; Postoperative Complications; Risk Factors; Thrombosis; Time Factors; Transplantation; Triazoles | 1997 |
8 trial(s) available for triazoles and Mucormycosis
| Article | Year |
|---|---|
Efficacy and safety of isavuconazole against deep-seated mycoses: A phase 3, randomized, open-label study in Japan.
Topics: Antifungal Agents; Aspergillosis; Cryptococcosis; Humans; Invasive Fungal Infections; Japan; Mucormycosis; Pulmonary Aspergillosis; Triazoles; Voriconazole | 2023 |
Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn).
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Drug Compounding; Female; Humans; Infant; Infant, Newborn; Invasive Fungal Infections; Male; Matched-Pair Analysis; Middle Aged; Mucorales; Mucormycosis; Prospective Studies; Registries; Triazoles; Young Adult | 2019 |
Isavuconazole Treatment of Invasive Fungal Sinusitis: A Post Hoc Analysis of the SECURE and VITAL Trials.
Topics: Antifungal Agents; Aspergillosis; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Sinusitis; Triazoles | 2021 |
Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species.
Topics: Administration, Intravenous; Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Coinfection; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Mucorales; Mucormycosis; Nitriles; Pyridines; Treatment Outcome; Triazoles | 2018 |
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.
Topics: Administration, Intravenous; Adult; Animals; Antifungal Agents; Aspergillosis; Female; Fungi; Humans; Male; Middle Aged; Mucormycosis; Nitriles; Pyridines; Treatment Outcome; Triazoles | 2016 |
Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Biological Availability; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Mucormycosis; Mucositis; Nitriles; Pyridines; Treatment Outcome; Triazoles; Young Adult | 2017 |
The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial.
Topics: Adult; Aged; Amphotericin B; Animals; Antifungal Agents; Benzoates; Deferasirox; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Iron Chelating Agents; Male; Mice; Middle Aged; Mucormycosis; Placebos; Survival Analysis; Treatment Outcome; Triazoles | 2012 |
Risk factors for mortality in patients with mucormycosis.
Topics: Adult; Aged; Amphotericin B; Benzoates; Deferasirox; Double-Blind Method; Ferritins; Humans; Iron; Kaplan-Meier Estimate; Lung Diseases; Middle Aged; Mucor; Mucormycosis; Risk Factors; Time Factors; Treatment Outcome; Triazoles | 2012 |
209 other study(ies) available for triazoles and Mucormycosis
| Article | Year |
|---|---|
Efficacy of Posaconazole against Rhizopus oryzae Infection in Silkworm.
Topics: Animals; Antifungal Agents; Bombyx; Humans; Mucormycosis; Rhizopus; Rhizopus oryzae; Triazoles | 2021 |
Successful treatment of pulmonary mucormycosis caused by Rhizopus microsporus with posaconazole.
Topics: Adult; Antifungal Agents; Humans; Lung; Lung Diseases; Male; Mucormycosis; Rhizopus; Treatment Outcome; Triazoles | 2021 |
Colon mucormycosis with renal spread resistant to lipid complex amphotericin and isavuconazole treatment in a heart transplant recipient.
Topics: Amphotericin B; Colon; Heart Transplantation; Humans; Lipids; Mucormycosis; Nitriles; Pyridines; Triazoles | 2022 |
Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non-fumigatus): A multicentre, non-interventional registry study.
Topics: Adult; Antifungal Agents; Aspergillosis; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Registries; Triazoles | 2022 |
Therapeutic drug monitoring of posaconazole delayed release tablet while managing COVID-19-associated mucormycosis in a real-life setting.
Topics: Administration, Oral; Antifungal Agents; COVID-19; Drug Monitoring; Female; Humans; Male; Middle Aged; Mucormycosis; Pandemics; Retrospective Studies; SARS-CoV-2; Tablets; Triazoles | 2022 |
A 67-Year-Old Male Patient With COVID-19 With Worsening Respiratory Function and Acute Kidney Failure.
Topics: Acute Kidney Injury; Aged; Amphotericin B; Antibodies, Monoclonal, Humanized; Antifungal Agents; Atrial Fibrillation; Bronchoscopy; COVID-19; Dexamethasone; Diabetes Mellitus, Type 2; Fatal Outcome; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mucormycosis; Nitriles; Obesity; Oxygen Inhalation Therapy; Pulmonary Aspergillosis; Pyridines; Respiration, Artificial; SARS-CoV-2; Smoking; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2022 |
Posaconazole or isavuconazole as sole or predominant antifungal therapy for COVID-19-associated mucormycosis. A retrospective observational case series.
Topics: Antifungal Agents; COVID-19; COVID-19 Drug Treatment; Humans; Mucormycosis; Nitriles; Pyridines; Retrospective Studies; Triazoles | 2022 |
Successful isavuconazole salvage therapy for cerebral mucormycosis in a child with relapsed leukemia: A light in the dark tunnel.
Topics: Antifungal Agents; Child; Humans; Leukemia; Mucormycosis; Nitriles; Salvage Therapy; Triazoles | 2023 |
Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice.
Topics: Adult; Antifungal Agents; Aspergillosis; Fungi; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Organ Transplantation; Retrospective Studies; Tacrolimus; Transplant Recipients; Triazoles | 2023 |
Context of instauration and evolution under isavuconazole, a 2-year prospective real-life study.
Topics: Animals; Antifungal Agents; Aspergillosis; Invasive Fungal Infections; Mucormycosis; Prospective Studies; Triazoles | 2023 |
Invasive mucormycosis during treatment for acute lymphoblastic leukaemia-successful management of two life-threatening diseases.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Humans; Invasive Fungal Infections; Lung Diseases, Fungal; Male; Mercaptopurine; Methotrexate; Mucorales; Mucormycosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Triazoles; Vincristine | 2020 |
Surgical-site mucormycosis infection in a solid-organ transplant recipient and a concise review of the literature.
Topics: Amphotericin B; Antifungal Agents; Debridement; Fatal Outcome; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Mucormycosis; Shock, Septic; Surgical Wound Infection; Transplant Recipients; Triazoles | 2019 |
Amphotericin-induced pancytopenia in a patient with rhino-orbital mucormycosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Debridement; Drug Substitution; Humans; Male; Mouth Diseases; Mucormycosis; Nose Diseases; Orbital Diseases; Palate; Pancytopenia; Triazoles | 2020 |
Primary cutaneous mucormycosis of the abdomen at the site of repeated insulin injections.
Topics: Abdomen; Aged; Anti-Bacterial Agents; Antifungal Agents; Dermatomycoses; Diabetes Mellitus, Type 2; Female; Humans; Immunocompromised Host; Injection Site Reaction; Injections, Subcutaneous; Insulin; Lung Neoplasms; Mucormycosis; Necrosis; Nitriles; Pyridines; Triazoles; Vancomycin | 2020 |
Rhizopus Infection in a Preterm Infant: A Novel Use of Posaconazole.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Humans; Infant, Newborn; Infant, Premature; Male; Micafungin; Microbial Sensitivity Tests; Mucormycosis; Rhizopus; Triazoles | 2020 |
Isavuconazole As Successful Salvage Therapy for Mucormycosis in Pediatric Patients.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Humans; Male; Mucormycosis; Nitriles; Pyridines; Salvage Therapy; Tertiary Healthcare; Tomography, X-Ray Computed; Triazoles; Young Adult | 2020 |
Disseminated Mucormycosis Due to Saksenaea vasiformis Complex in an Immunocompetent Adult with Sustained Response to Posaconazole Treatment.
Topics: Aged; Antifungal Agents; Asian People; Back; Follow-Up Studies; Forehead; Humans; Immunocompetence; Male; Mucormycosis; Positron Emission Tomography Computed Tomography; Singapore; Skin; Thorax; Tomography, X-Ray Computed; Triazoles | 2020 |
Comparative immunopathogenesis in a murine model of inhalative infection with the mucormycetes Lichtheimia corymbifera and Rhizopus arrhizus.
Topics: Animals; Disease Models, Animal; Female; Inhalation; Mice; Mice, Inbred C57BL; Mucorales; Mucormycosis; Rhizopus; Survival Analysis; Triazoles | 2020 |
Successful treatment of cutaneous mucormycosis disseminated from pulmonary mucormycosis with liposomal amphotericin B and posaconazole.
Topics: Amphotericin B; Antifungal Agents; Humans; Mucormycosis; Triazoles | 2020 |
The cost-effectiveness of isavuconazole compared to voriconazole, the standard of care in the treatment of patients with invasive mould diseases, prior to differential pathogen diagnosis in Spain.
Topics: Antifungal Agents; Aspergillosis; Clinical Laboratory Techniques; Cost-Benefit Analysis; Diagnosis, Differential; Fungi; Hospitalists; Humans; Mucormycosis; Nitriles; Pyridines; Spain; Standard of Care; Triazoles; Voriconazole | 2021 |
Latest Thoughts on Treating Pediatric Mucormycosis.
Topics: Amphotericin B; Antifungal Agents; Biopsy; Child; Debridement; Humans; Immunocompromised Host; Invasive Fungal Infections; Mucorales; Mucormycosis; Salvage Therapy; Tomography, X-Ray Computed; Triazoles | 2020 |
Isolated cerebral mucormycosis associated with intravenous drug use.
Topics: Amphotericin B; Central Nervous System Fungal Infections; Cocaine; Cocaine-Related Disorders; Drug Therapy, Combination; Drug Users; Humans; Magnetic Resonance Imaging; Male; Marijuana Abuse; Middle Aged; Mucormycosis; Nitriles; Pyridines; Substance Abuse, Intravenous; Triazoles | 2020 |
Diagnosis of oesophageal mucormycosis managed with medical therapy alone.
Topics: Amphotericin B; Antifungal Agents; Cytarabine; Esophageal Diseases; Esophagus; Humans; Idarubicin; Immunocompromised Host; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Mucormycosis; Rhizopus; Triazoles | 2020 |
Oral posaconazole and bronchoscopy as a treatment for pulmonary mucormycosis in pediatric acute lymphoblastic leukemia patient: A case report.
Topics: Administration, Oral; Antifungal Agents; Child; Diagnosis, Differential; Fever; Humans; Immunocompromised Host; Lung Diseases, Fungal; Male; Mucormycosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Triazoles | 2021 |
A 51-Year-Old Woman With a Mediastinal Mass.
Topics: Amphotericin B; Antifungal Agents; Bronchoscopy; Diagnosis, Differential; Female; Humans; Lung; Lung Diseases; Middle Aged; Mucormycosis; Nitriles; Pneumonectomy; Pyridines; Respiration, Artificial; Thoracic Surgery, Video-Assisted; Treatment Outcome; Triazoles | 2021 |
Frequency of occurrence, seasonal variation and antifungal susceptibility of opportunistic Mucorales isolated from hospital soils in Iran.
Topics: Amphotericin B; Antifungal Agents; Cunninghamella; Hospitals; Humans; Iran; Microbial Sensitivity Tests; Mucor; Mucorales; Mucormycosis; Opportunistic Infections; Rhizopus; Seasons; Soil; Soil Microbiology; Triazoles | 2021 |
Clinical utility of antifungal susceptibility testing in patients with fungal rhinosinusitis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Azoles; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Mycoses; Sinusitis; Triazoles; Voriconazole | 2021 |
Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicentre study from Iran.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Coinfection; Comorbidity; COVID-19; COVID-19 Drug Treatment; Cross-Sectional Studies; Diabetes Complications; Diabetes Mellitus; Drug Therapy, Combination; Female; Humans; Iran; Male; Middle Aged; Mucormycosis; Respiratory Distress Syndrome; Triazoles; Young Adult | 2021 |
Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Mice; Mucor; Mucormycosis; Nitriles; Pyridines; Rhizopus; Triazoles | 2021 |
Drug repurposing of triazoles against mucormycosis using molecular docking: A short communication.
Topics: Antifungal Agents; COVID-19; Drug Repositioning; Humans; Molecular Docking Simulation; Mucormycosis; SARS-CoV-2; Triazoles | 2021 |
New pharmacological opportunities for the treatment of invasive mould diseases.
Topics: Amphotericin B; Anidulafungin; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Echinocandins; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Triazoles; Voriconazole | 2017 |
Mucormycosis in renal transplant recipients: review of 174 reported cases.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Child; Debridement; Deoxycholic Acid; Diabetes Mellitus; Female; Humans; Immunocompromised Host; Kidney Transplantation; Male; Middle Aged; Mucormycosis; Rhizopus; Transplant Recipients; Triazoles; Young Adult | 2017 |
Rhinocerebral Mucormycosis: Report of a Rare Case.
Topics: Aged; Amphotericin B; Antifungal Agents; Humans; Male; Mucormycosis; Necrosis; Paranasal Sinuses; Tomography, X-Ray Computed; Triazoles | 2017 |
Topics: Aged, 80 and over; Amphotericin B; Antifungal Agents; Australia; Debridement; Humans; Leg Injuries; Male; Mucormycosis; Soft Tissue Infections; Treatment Outcome; Triazoles | 2017 |
Prophylactic Treatment with VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus Infection.
Topics: Animals; Antifungal Agents; Immunocompromised Host; Male; Mice; Microbial Sensitivity Tests; Mucormycosis; Protective Agents; Pyridines; Rhizopus; Tetrazoles; Triazoles | 2017 |
Saksenaea vasiformis Orbital Cellulitis in an Immunocompetent Child Treated With Posaconazole.
Topics: Antifungal Agents; Child; Combined Modality Therapy; Debridement; Female; Humans; Immunocompetence; Mucorales; Mucormycosis; Orbital Cellulitis; Triazoles | 2018 |
Topics: Adult; Amphotericin B; Antifungal Agents; Diabetes Complications; Diabetes Mellitus; Female; Humans; Immunocompromised Host; Male; Maxillary Sinus; Middle Aged; Mucorales; Mucormycosis; Opportunistic Infections; Sinusitis; Tooth Extraction; Treatment Outcome; Triazoles | 2018 |
On the Nose: Disseminated Mucormycosis.
Topics: Aged; Amphotericin B; Antifungal Agents; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Lung Diseases; Male; Mucormycosis; Nose Diseases; Pancytopenia; Treatment Outcome; Triazoles | 2018 |
Economic impact of treating invasive mold disease with isavuconazole compared with liposomal amphotericin B in the UK.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Costs and Cost Analysis; Drug Costs; Health Care Costs; Humans; Models, Economic; Mucormycosis; Nitriles; Pyridines; Treatment Outcome; Triazoles; United Kingdom | 2018 |
Cutaneous mucormycosis caused by Rhizopus microsporus in an immunocompetent patient: A case report and review of literature.
Topics: Adult; Antifungal Agents; Bacteriological Techniques; Dermatomycoses; Humans; Immunologic Tests; Male; Mucormycosis; Rhizopus; Treatment Outcome; Triazoles | 2018 |
Galleria mellonella as a model system to study virulence potential of mucormycetes and evaluation of antifungal treatment.
Topics: Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Drug Resistance, Fungal; Larva; Lepidoptera; Microbial Sensitivity Tests; Mucor; Mucorales; Mucormycosis; Nitriles; Pyridines; Rhizopus; Triazoles; Virulence | 2019 |
Successful treatment of invasive mucormycosis with isavuconazole in pediatric patients.
Topics: Adolescent; Antifungal Agents; Antineoplastic Agents; Child, Preschool; Female; Hodgkin Disease; Humans; Immunocompromised Host; Male; Mucormycosis; Nitriles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyridines; Treatment Outcome; Triazoles | 2018 |
Widespread Lichtheimia Infection in a Patient with Extensive Burns: Opportunities for Novel Antifungal Agents.
Topics: Amphotericin B; Antifungal Agents; Burns; Debridement; Dermatomycoses; Humans; Male; Middle Aged; Mucorales; Mucormycosis; Nitriles; Pyridines; Treatment Outcome; Triazoles | 2019 |
Cutaneous mucormycosis.
Topics: Aged; Amphotericin B; Antifungal Agents; Debridement; Dermatomycoses; Humans; Male; Mucormycosis; Triazoles | 2018 |
Renal Mucormycosis: A Rare Cause of Urinary Tract Infection Leading to End-stage Renal Disease (ESRD).
Topics: Abdominal Pain; Amphotericin B; Antifungal Agents; Child, Preschool; Dialysis; Fever; Humans; Kidney; Kidney Failure, Chronic; Magnetic Resonance Imaging; Male; Mucorales; Mucormycosis; Pyelonephritis; Treatment Outcome; Triazoles; Urinary Tract Infections; Vomiting | 2019 |
Isolated renal mucormycosis in a patient with Idiopathic CD4 lymphocytopenia.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Combined Modality Therapy; Diagnosis, Differential; Female; Humans; Kidney; Kidney Diseases; Mucormycosis; T-Lymphocytopenia, Idiopathic CD4-Positive; Triazoles | 2018 |
An Unusual Case of Pulmonary Mucormycosis.
Topics: Amphotericin B; Antifungal Agents; Humans; Immunocompromised Host; Kidney Transplantation; Lung Diseases, Fungal; Male; Middle Aged; Mucorales; Mucormycosis; Transplant Recipients; Triazoles | 2018 |
Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Brain Diseases; Combined Modality Therapy; Debridement; Deoxycholic Acid; Eye Infections, Fungal; Female; Humans; Male; Middle Aged; Mucormycosis; Natural Orifice Endoscopic Surgery; Orbital Diseases; Paranasal Sinus Diseases; Retrospective Studies; Treatment Outcome; Triazoles; Young Adult | 2019 |
Successful outcome of disseminated mucormycosis in a 3-year-old child suffering from acute leukaemia: the role of isavuconazole? A case report.
Topics: Acute Disease; Amphotericin B; Antifungal Agents; Child, Preschool; Drug Therapy, Combination; Female; Humans; Leukemia, B-Cell; Mucormycosis; Nitriles; Pyridines; Treatment Outcome; Triazoles | 2018 |
Cutaneous mucormycosis.
Topics: Aged; Amphotericin B; Antifungal Agents; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Invasive Fungal Infections; Male; Mucormycosis; Multiple Organ Failure; Rhizopus; Shock, Septic; Skin; Triazoles | 2019 |
Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Case-Control Studies; Cost-Benefit Analysis; Decision Trees; Female; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Quality-Adjusted Life Years; Sweden; Triazoles; Voriconazole | 2019 |
A Rare Case of Pulmonary Coinfection by Lichtheimia ramosa and Aspergillus fumigatus in a Patient With Delayed Graft Function After Renal Transplantation.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Coinfection; Delayed Graft Function; Humans; Immunocompromised Host; Kidney Transplantation; Male; Mucorales; Mucormycosis; Respiratory Tract Infections; Triazoles | 2019 |
In vitro interactions between isavuconazole and tacrolimus, cyclosporin A or sirolimus against Mucorales.
Topics: Antifungal Agents; Cyclosporine; Immunosuppressive Agents; Microbial Sensitivity Tests; Mucorales; Mucormycosis; Nitriles; Pyridines; Sirolimus; Tacrolimus; Triazoles | 2019 |
Overview and outcome of mucormycosis among children with cancer: Report from the Children's Cancer Hospital Egypt.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Cancer Care Facilities; Child; Child, Preschool; Egypt; Female; Hematologic Neoplasms; Hospitals, Pediatric; Humans; Immunocompromised Host; Male; Mucormycosis; Neoplasms; Opportunistic Infections; Retrospective Studies; Risk Factors; Treatment Outcome; Triazoles | 2019 |
Mucormycosis: More Than Meets the Eye!
Topics: Adult; Amphotericin B; Antifungal Agents; Cavernous Sinus Thrombosis; Debridement; Delayed Diagnosis; Diabetes Complications; Humans; Magnetic Resonance Imaging; Male; Mucormycosis; Ophthalmoplegia; Opportunistic Infections; Orbit Evisceration; Orbital Cellulitis; Sinusitis; Triazoles | 2019 |
Disseminated mucormycosis.
Topics: Antifungal Agents; Female; Humans; Leukemia, Myeloid; Middle Aged; Mucormycosis; Nitriles; Opportunistic Infections; Pyridines; Respiratory Insufficiency; Shock, Septic; Tomography, X-Ray Computed; Triazoles | 2019 |
A Revised Species Concept for Opportunistic
Topics: Amphotericin B; Antifungal Agents; Humans; Itraconazole; Microbial Sensitivity Tests; Mucor; Mucormycosis; Natamycin; Nitriles; Pyridines; Rhizopus; Species Specificity; Terbinafine; Triazoles | 2019 |
Transdiaphragmatic Mucormycosis.
Topics: Antifungal Agents; Humans; Mucormycosis; Triazoles | 2020 |
[Hemoptysis complicating bronchopulmonary mucormycosis in a diabetic patient].
Topics: Aged, 80 and over; Amphotericin B; Combined Modality Therapy; Diabetes Mellitus, Type 2; Hemoptysis; Humans; Lung Diseases, Fungal; Male; Mucormycosis; Opportunistic Infections; Pneumonectomy; Triazoles | 2013 |
Mucormycosis in a patient with acute myeloid leukemia successfully treated with liposomal amphotericin B associated with deferasirox and hyperbaric oxygen.
Topics: Adult; Amphotericin B; Antifungal Agents; Benzoates; Bone Marrow; Deferasirox; Drug Therapy, Combination; Female; Humans; Hyperbaric Oxygenation; Immunophenotyping; Karyotyping; Leukemia, Myeloid, Acute; Mucormycosis; Nucleophosmin; Treatment Outcome; Triazoles | 2013 |
Successful treatment of rhino-orbital mucormycosis with posaconazole and hyperbaric oxygen therapy.
Topics: Adult; Amphotericin B; Antifungal Agents; Child, Preschool; Combined Modality Therapy; Female; Humans; Hyperbaric Oxygenation; Mucormycosis; Orbital Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Rhizopus; Tomography, X-Ray Computed; Triazoles | 2013 |
Drug combinations against Mucor irregularis in vitro.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Combinations; Drug Synergism; Echinocandins; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mucor; Mucormycosis; Naphthalenes; Terbinafine; Triazoles | 2013 |
Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Cortisone; Cyclophosphamide; Diabetic Ketoacidosis; Disease Models, Animal; Male; Mice; Mice, Inbred ICR; Mice, Inbred NOD; Microbial Sensitivity Tests; Mucorales; Mucormycosis; Triazoles | 2013 |
Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Follow-Up Studies; Hematologic Diseases; Humans; Mucormycosis; Registries; Treatment Outcome; Triazoles | 2013 |
Rhizopus keratitis following corneal trauma.
Topics: Administration, Ophthalmic; Administration, Oral; Antifungal Agents; Bacteriological Techniques; Corneal Injuries; Corneal Ulcer; Diagnostic Techniques, Ophthalmological; Eye Infections, Fungal; Eye Injuries, Penetrating; Humans; Male; Middle Aged; Mucormycosis; Pyrimidines; Rhizopus; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Dried blood spot analysis suitable for therapeutic drug monitoring of voriconazole, fluconazole, and posaconazole.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Dried Blood Spot Testing; Drug Monitoring; Fluconazole; Humans; Middle Aged; Mucormycosis; Mycoses; Triazoles; Young Adult | 2013 |
Posaconazole treatment in Korea: single-center experience over 5 years.
Topics: Adult; Aged; Antifungal Agents; Female; Humans; Immunocompromised Host; Male; Middle Aged; Mucormycosis; Mycoses; Republic of Korea; Salvage Therapy; Triazoles | 2013 |
Invasive mucormycosis without radiological alterations.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Female; Fungi; Humans; Liposomes; Mucormycosis; Neutropenia; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Stem Cell Transplantation; Tomography, X-Ray Computed; Triazoles | 2013 |
Successful isavuconazole salvage therapy in a patient with invasive mucormycosis.
Topics: Antifungal Agents; Brain Diseases; Humans; Male; Middle Aged; Mucormycosis; Nitriles; Pyridines; Rhizopus; Salvage Therapy; Treatment Outcome; Triazoles | 2014 |
[Pulmonary mucormycosis: report of 5 cases and review of 46 cases reported in China].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Biopsy, Needle; Bronchoscopy; Drug Therapy, Combination; Female; Humans; Lung; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Risk Factors; Tomography, X-Ray Computed; Triazoles; Young Adult | 2013 |
Isavuconazole treatment of a patient with disseminated mucormycosis.
Topics: Antifungal Agents; Brain; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Lung; Male; Middle Aged; Mucormycosis; Nitriles; Pyridines; Rhizomucor; Skin; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Triazoles | 2014 |
Isavuconazole therapy protects immunosuppressed mice from mucormycosis.
Topics: Animals; Antifungal Agents; Immunosuppression Therapy; Male; Mice; Mice, Inbred ICR; Mucormycosis; Nitriles; Pyridines; Triazoles | 2014 |
Reverse halo sign in pulmonary mucormyosis.
Topics: Amphotericin B; Antifungal Agents; Biopsy, Fine-Needle; Humans; Image-Guided Biopsy; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Mucormycosis; Multiple Pulmonary Nodules; Tomography, X-Ray Computed; Treatment Outcome; Triazoles | 2014 |
Histopathological evidence of invasive gastric mucormycosis after transarterial chemoembolization and liver transplantation.
Topics: Amphotericin B; Antifungal Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Diabetes Complications; Female; Hepatitis B, Chronic; Histocytochemistry; Humans; Immunocompromised Host; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Microscopy; Middle Aged; Mucorales; Mucormycosis; Stomach Diseases; Triazoles | 2014 |
[Cutaneous mucormycosis as a rare complication of a liver transplantation].
Topics: Abdominal Wall; Acute Kidney Injury; Adult; Amphotericin B; Anti-Infective Agents; Antibiotic Prophylaxis; Antifungal Agents; Clostridium Infections; Cytomegalovirus Infections; Debridement; Dermatomycoses; Hepatitis; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Mucormycosis; Opportunistic Infections; Postoperative Complications; Primary Graft Dysfunction; Reoperation; Triazoles | 2014 |
Pharmacokinetics of oral isavuconazole in a patient after Roux-en-Y gastric bypass surgery.
Topics: Administration, Oral; Antifungal Agents; Gastric Bypass; Humans; Lung Diseases, Fungal; Microbial Sensitivity Tests; Middle Aged; Mucormycosis; Nitriles; Pyridines; Rhizopus; Triazoles | 2014 |
In vitro combination of isavuconazole with micafungin or amphotericin B deoxycholate against medically important molds.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Cunninghamella; Deoxycholic Acid; Drug Combinations; Drug Interactions; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mucormycosis; Nitriles; Pyridines; Triazoles | 2014 |
Comparative pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary aspergillosis and mucormycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus fumigatus; Benzoates; Caspofungin; Deferasirox; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Female; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mucormycosis; Neutropenia; Rhizopus; Treatment Outcome; Triazoles | 2014 |
Clinical challenge: fatal mucormycotic osteomyelitis caused by Rhizopus microsporus despite aggressive multimodal treatment.
Topics: Aged; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Combined Modality Therapy; Fatal Outcome; Humans; Male; Mucormycosis; Osteomyelitis; Rhizopus; Triazoles | 2014 |
Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India.
Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; DNA, Fungal; Drug Resistance, Fungal; Humans; India; Itraconazole; Microbial Sensitivity Tests; Mucor; Mucorales; Mucormycosis; Mycological Typing Techniques; Nitriles; Pyridines; Rhizopus; Sequence Analysis, DNA; Specimen Handling; Triazoles | 2014 |
Disseminated Mucormycosis With Cerebral Involvement Owing to Rhizopus Microsporus in a Kidney Recipient Treated With Combined Liposomal Amphotericin B and Posaconazole Therapy.
Topics: Amphotericin B; Antifungal Agents; Central Nervous System Fungal Infections; Diagnosis, Differential; Drug Therapy, Combination; Fatal Outcome; Humans; Kidney Transplantation; Magnetic Resonance Imaging; Male; Middle Aged; Mucormycosis; Predictive Value of Tests; Rhizopus; Tomography, X-Ray Computed; Treatment Outcome; Triazoles | 2016 |
Lingual necrosis caused by mucormycosis in a patient with aplastic anaemia: case report.
Topics: Aged, 80 and over; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Escherichia coli Infections; Fatal Outcome; Female; Humans; Immunocompromised Host; Mucormycosis; Necrosis; Rhizopus; Tongue; Triazoles | 2014 |
Keratitis caused by Absidia corymbifera in an immunocompetent male with no corneal injuries.
Topics: Absidia; Administration, Ophthalmic; Adrenal Cortex Hormones; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Combined Modality Therapy; Corneal Transplantation; Corneal Ulcer; Drug Therapy, Combination; Humans; Immunocompetence; Male; Middle Aged; Mucormycosis; Ophthalmic Solutions; Staining and Labeling; Triazoles; Voriconazole | 2015 |
Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Multiple, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Mucorales; Mucormycosis; Triazoles | 2015 |
Muscle diffusion of liposomal amphotericin B and posaconazole in critically ill burn patients receiving continuous hemodialysis.
Topics: Amphotericin B; Antifungal Agents; Burns; Critical Illness; Diffusion; Humans; Liposomes; Mucormycosis; Muscles; Renal Dialysis; Triazoles | 2015 |
Posaconazole liquid suspension in solid organ transplant recipients previously treated with voriconazole.
Topics: Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Mucormycosis; Mycoses; Transplant Recipients; Transplants; Triazoles; Voriconazole | 2015 |
Successful Treatment of Primary Cutaneous Mucormycosis Complicating Anti-TNF Therapy with a Combination of Surgical Debridement and Oral Posaconazole.
Topics: Antifungal Agents; Arthritis, Psoriatic; Debridement; Dermatomycoses; Diabetes Complications; Etanercept; Female; Humans; Immunosuppressive Agents; Middle Aged; Mucormycosis; Prednisone; Treatment Outcome; Triazoles; Wounds and Injuries | 2015 |
Effect of Preexposure to Triazoles on Susceptibility and Virulence of Rhizopus oryzae.
Topics: Agar; Animals; Antifungal Agents; Culture Media; Disease Models, Animal; Drosophila melanogaster; Female; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Rhizopus; Survival Analysis; Triazoles; Virulence; Voriconazole | 2015 |
Comparison of the EUCAST and CLSI Broth Microdilution Methods for Testing Isavuconazole, Posaconazole, and Amphotericin B against Molecularly Identified Mucorales Species.
Topics: Amphotericin B; Antifungal Agents; Humans; Microbial Sensitivity Tests; Mucorales; Mucormycosis; Nitriles; Pyridines; Species Specificity; Triazoles; Voriconazole | 2015 |
In Vitro Activity of Isavuconazole and Comparators against Clinical Isolates of the Mucorales Order.
Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Mucorales; Mucormycosis; Nitriles; Pyridines; Species Specificity; Triazoles | 2015 |
Primary cutaneous mucormycosis developing after incision and drainage of a subcutaneous abscess in an immunocompetent host.
Topics: Abscess; Adult; Amphotericin B; Antifungal Agents; Drainage; Humans; Immunocompetence; Leg; Male; Methicillin-Resistant Staphylococcus aureus; Mucormycosis; Postoperative Complications; Skin Diseases; Staphylococcal Infections; Triazoles | 2016 |
Laryngotracheal mucormycosis: Report of a case.
Topics: Antifungal Agents; Burkitt Lymphoma; Debridement; Dysphonia; Echinocandins; Hepatitis C, Chronic; HIV Infections; Humans; Hyperbaric Oxygenation; Laryngitis; Laryngoscopy; Lipopeptides; Male; Micafungin; Middle Aged; Mucormycosis; Neurosyphilis; Respiratory Distress Syndrome; Respiratory Sounds; Tracheitis; Tracheotomy; Triazoles | 2016 |
Isavuconazole: an azole active against mucormycosis.
Topics: Antifungal Agents; Azoles; Humans; Mucormycosis; Nitriles; Pyridines; Triazoles | 2016 |
Isavuconazole Population Pharmacokinetic Analysis Using Nonparametric Estimation in Patients with Invasive Fungal Disease (Results from the VITAL Study).
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Female; Humans; Linear Models; Male; Microbial Sensitivity Tests; Mucormycosis; Nitriles; Pyridines; Triazoles | 2016 |
Utilization of posaconazole oral suspension or delayed-released tablet salvage treatment for invasive fungal infection.
Topics: Administration, Oral; Adult; Aged; Alternaria; Antifungal Agents; Aspergillus; Delayed-Action Preparations; Fatal Outcome; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Mucormycosis; Retrospective Studies; Salvage Therapy; Suspensions; Tablets; Treatment Outcome; Triazoles | 2016 |
Posaconazole: an emerging therapeutic option for invasive rhino-orbito-cerebral mucormycosis.
Topics: Adult; Antifungal Agents; Brain Diseases; Female; Humans; Male; Middle Aged; Mucorales; Mucormycosis; Nose Diseases; Orbital Diseases; Retrospective Studies; Triazoles; Young Adult | 2016 |
Successful Nonsurgical Eradication of Invasive Gastric Mucormycosis.
Topics: Aged; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Gastrointestinal Diseases; Humans; Male; Mucormycosis; Treatment Outcome; Triazoles | 2016 |
Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis.
Topics: Animals; Antifungal Agents; Drug Therapy, Combination; Echinocandins; Lipopeptides; Lung; Male; Micafungin; Mice; Microbial Sensitivity Tests; Mucor; Mucormycosis; Nitriles; Pyridines; Rhizopus; Triazoles | 2017 |
Successful Treatment of Rhino-Orbital-Cerebral Mucormycosis in a Child With Leukemia.
Topics: Amphotericin B; Antifungal Agents; Brain; Child, Preschool; Female; Humans; Hyperbaric Oxygenation; Mucormycosis; Naphthalenes; Nose; Opportunistic Infections; Orbit; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Terbinafine; Triazoles | 2017 |
Skin lesion in a patient with acute myeloid leukemia.
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Biopsy; Debridement; Dermatomycoses; Febrile Neutropenia; Forearm; Humans; Immunocompromised Host; Induction Chemotherapy; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Mucormycosis; Polymerase Chain Reaction; Rhizopus; RNA, Fungal; Triazoles | 2017 |
Cerebral Rhizomucor Infection Treated by Posaconazole Delayed-Release Tablets in an Allogeneic Stem Cell Transplant Recipient.
Topics: Adult; Antifungal Agents; Delayed-Action Preparations; Fatal Outcome; Female; Humans; Immunocompromised Host; Leukemia, Myelomonocytic, Acute; Mucormycosis; Rhizomucor; Stem Cell Transplantation; Tablets; Transplantation, Homologous; Triazoles | 2017 |
Mucormycosis pulmonary abscess, containment in a patient with uncontrolled diabetes mellitus.
Topics: Antifungal Agents; Diabetes Complications; Diabetes Mellitus; Humans; Lung Abscess; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Pneumonectomy; Radiography, Thoracic; Surgical Flaps; Tomography, X-Ray Computed; Triazoles | 2017 |
[Mucormycosis cutanea- clinical case presentation souvenir etiopatogenia diagnosis and treatment].
Topics: Aged; Amphotericin B; Antifungal Agents; Debridement; Fatal Outcome; Humans; Male; Mucormycosis; Risk Factors; Triazoles | 2016 |
The cost of treating mucormycosis with isavuconazole compared with standard therapy in the UK.
Topics: Amphotericin B; Antifungal Agents; Case-Control Studies; Drug Costs; Hospitalization; Humans; Invasive Fungal Infections; Models, Economic; Mucormycosis; Nitriles; Pyridines; Triazoles; United Kingdom | 2017 |
Prophylaxis with Isavuconazole or Posaconazole Protects Immunosuppressed Mice from Pulmonary Mucormycosis.
Topics: Animals; Antibiotic Prophylaxis; Antifungal Agents; Disease Models, Animal; Immunosuppression Therapy; Lung Diseases, Fungal; Mice; Mucormycosis; Nitriles; Pyridines; Rhizopus; Triazoles; Voriconazole | 2017 |
Investigation and management of an outbreak of mucormycosis in a paediatric oncology unit.
Topics: Adolescent; Antifungal Agents; Chemoprevention; Cross Infection; Disease Outbreaks; Environmental Microbiology; Hospital Units; Hospitals, University; Humans; Infant; Infection Control; Male; Mucormycosis; Neoplasms; Triazoles | 2008 |
Breakthrough Rhizopus infection on posaconazole prophylaxis following allogeneic stem cell transplantation.
Topics: Antifungal Agents; Humans; Lymphoma, Follicular; Male; Middle Aged; Mucormycosis; Rhinitis; Rhizopus; Sinusitis; Stem Cell Transplantation; Time Factors; Transplantation, Homologous; Triazoles | 2008 |
Infection of the subcutis of the nose in a cat caused by Mucor species: successful treatment using posaconazole.
Topics: Animals; Antifungal Agents; Cat Diseases; Cats; Female; Mucor; Mucormycosis; Treatment Outcome; Triazoles | 2008 |
Posaconazole combined with amphotericin B, an effective therapy for a murine disseminated infection caused by Rhizopus oryzae.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Humans; Male; Mice; Mucormycosis; Rhizopus; Triazoles | 2008 |
Breakthrough invasive fungal infection in an immunocompromised host while on posaconazole prophylaxis: an omission in patient counseling and follow-up.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Candidiasis; Female; Humans; Immunosuppression Therapy; Leukemia, Myeloid, Acute; Middle Aged; Mucormycosis; Paranasal Sinus Diseases; Patient Compliance; Patient Education as Topic; Triazoles | 2008 |
Long-term posaconazole treatment and follow-up of rhino-orbital-cerebral mucormycosis in a diabetic girl.
Topics: Antifungal Agents; Central Nervous System Diseases; Child; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Female; Follow-Up Studies; Humans; Mucormycosis; Nose Diseases; Orbital Diseases; Time Factors; Treatment Outcome; Triazoles | 2009 |
Disseminated Saksenaea vasiformis in an immunocompetent host.
Topics: Amphotericin B; Antifungal Agents; Child; Fungemia; Humans; Immunocompetence; Male; Mucorales; Mucormycosis; Plastic Surgery Procedures; Surgical Flaps; Triazoles | 2008 |
Clinical experience with posaconazole in patients with invasive mucormycosis: a case series.
Topics: Adult; Antifungal Agents; Humans; Male; Middle Aged; Mucormycosis; Triazoles | 2008 |
Treatment of intestinal and hepatic mucormycosis in an immunocompromized child.
Topics: Antifungal Agents; Antineoplastic Agents, Phytogenic; Child, Preschool; Drug Therapy, Combination; Humans; Immunocompromised Host; Intestinal Diseases; Liver Diseases; Magnetic Resonance Imaging; Male; Mucormycosis; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Tomography, X-Ray Computed; Triazoles; Vincristine | 2009 |
Disseminated Rhizopus microsporus infection in a patient on oral corticosteroid treatment: a case report.
Topics: Adrenal Cortex Hormones; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antifungal Agents; Ciprofloxacin; Fatal Outcome; Humans; Itraconazole; Male; Mucormycosis; Prednisolone; Pyrimidines; Rhizopus; Triazoles; Voriconazole | 2009 |
Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Synergism; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Rhizopus; Triazoles; Voriconazole | 2008 |
[Invasive pulmonary mucormycosis with invasion of the thoracic spine in a patient with myelodysplastic syndrome].
Topics: Aged; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fatal Outcome; Humans; Immunocompromised Host; Laminectomy; Lung Diseases, Fungal; Male; Mucormycosis; Myelodysplastic Syndromes; Spinal Diseases; Thoracic Vertebrae; Triazoles | 2008 |
Posaconazole for bone-invading rhinomaxillary mucormycosis.
Topics: Aged, 80 and over; Antifungal Agents; Female; Humans; Maxillary Diseases; Mucormycosis; Paranasal Sinus Diseases; Triazoles | 2009 |
[Amphotericin and posaconazole for gastrointestinal mucormycosis].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Arthritis, Rheumatoid; Colitis, Ulcerative; Combined Modality Therapy; Drainage; Fatal Outcome; Gastrointestinal Diseases; Humans; Ileal Diseases; Intestinal Perforation; Intraoperative Complications; Jejunal Diseases; Liposomes; Male; Mucormycosis; Peritonitis; Postoperative Complications; Shock, Septic; Triazoles | 2009 |
[Two cases of mycoses associated with hematologic disease].
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cunninghamella; Fatal Outcome; Humans; Liposomes; Male; Mucormycosis; Myelodysplastic Syndromes; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Safety and outcomes of open-label deferasirox iron chelation therapy for mucormycosis.
Topics: Adult; Aged; Benzoates; Chelation Therapy; Deferasirox; Exanthema; Female; Humans; Iron Chelating Agents; Male; Middle Aged; Mucormycosis; Treatment Outcome; Triazoles | 2009 |
Rhinocerebral mucormycosis.
Topics: Aged; Antifungal Agents; Brain Diseases; Diabetes Complications; Fatal Outcome; Female; Humans; Mucormycosis; Nose Diseases; Triazoles | 2009 |
Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Kidney; Male; Mice; Mucormycosis; Rhizopus; Triazoles | 2009 |
Emerging therapeutic options in fulminant invasive rhinocerebral mucormycosis.
Topics: Aged; Antifungal Agents; Central Nervous System Bacterial Infections; Female; Humans; Male; Mucormycosis; Rhinitis; Severity of Illness Index; Triazoles | 2010 |
[Non-fatal disseminated mucormycosis in a solid organ transplant].
Topics: Absidia; Adult; Amphotericin B; Antifungal Agents; Combined Modality Therapy; Debridement; Female; Humans; Lung Diseases, Fungal; Lung Transplantation; Mucormycosis; Opportunistic Infections; Thyroid Diseases; Triazoles | 2009 |
Breakthrough zygomycosis on posaconazole prophylaxis after allogeneic stem cell transplantation.
Topics: Amphotericin B; Antifungal Agents; Chemoprevention; Drug Therapy, Combination; Fatal Outcome; Graft vs Host Disease; Humans; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Pneumonia; Rhizopus; Stem Cell Transplantation; Transplantation, Homologous; Triazoles | 2010 |
Successful treatment of ascending aortic graft and valve endocarditis after debulking splenectomy for invasive aspergillosis and mucor.
Topics: Aneurysm; Antifungal Agents; Aortic Aneurysm, Thoracic; Arterial Occlusive Diseases; Aspergillosis; Blood Vessel Prosthesis; Endocarditis; Femoral Artery; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mucormycosis; Popliteal Artery; Prosthesis-Related Infections; Splenectomy; Triazoles | 2009 |
Current controversies in treating invasive zygomycosis.
Topics: Amphotericin B; Antifungal Agents; Cunninghamella; Drug Therapy, Combination; Humans; Lung Diseases, Fungal; Mucormycosis; Pyrimidines; Triazoles; Voriconazole | 2010 |
Successful triple combination therapy of disseminated absidia corymbifera infection in an adolescent with osteosarcoma.
Topics: Absidia; Adolescent; Amphotericin B; Antineoplastic Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Femoral Neoplasms; Humans; Lipopeptides; Mucormycosis; Opportunistic Infections; Osteosarcoma; Triazoles | 2010 |
Report of a successful treatment of pulmonary Cunninghamella bertholletiae infection with liposomal amphotericin and posaconazole in a child with GvHD and review of the literature.
Topics: Amphotericin B; Bone Marrow Transplantation; Child; Cunninghamella; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Lung Diseases, Fungal; Mucormycosis; Triazoles | 2010 |
Malignant thymoma with immunodeficiency (Good syndrome) associated with mucormycosis.
Topics: Abdominal Abscess; Agammaglobulinemia; Aged; Antifungal Agents; Humans; Male; Mucormycosis; Thymoma; Thymus Neoplasms; Triazoles | 2010 |
Correlation between in vitro activity of posaconazole and in vivo efficacy against Rhizopus oryzae infection in mice.
Topics: Animals; Antifungal Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Fungal; In Vitro Techniques; Kaplan-Meier Estimate; Kidney; Mice; Mucormycosis; Rhizopus; Triazoles | 2010 |
Disseminated Rhizopus microsporus infection cured by salvage allogeneic hematopoietic stem cell transplantation, antifungal combination therapy, and surgical resection.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Middle Aged; Mucormycosis; Rhizopus; Salvage Therapy; Transplantation, Homologous; Treatment Outcome; Triazoles | 2010 |
Severe life threatening neurotoxicity in a child with acute lymphoblastic leukemia receiving posaconazole and vincristine.
Topics: Antifungal Agents; Antineoplastic Agents, Phytogenic; Child, Preschool; Drug Interactions; Drug Therapy, Combination; Humans; Male; Mucormycosis; Neurotoxicity Syndromes; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Triazoles; Vincristine | 2010 |
A noninvasive renal fungus ball caused by Rhizopus--a previously unreported manifestation of zygomycosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Humans; Kidney Diseases; Kidney Pelvis; Male; Mucormycosis; Renal Insufficiency; Rhizopus; Triazoles; Ureter | 2010 |
Use of posaconazole in the treatment of infective rhinocerebral mucormycosis.
Topics: Antifungal Agents; Brain Diseases; Diabetes Mellitus, Type 2; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mucormycosis; Orbital Diseases; Paranasal Sinus Diseases; Rhizopus; Triazoles | 2010 |
Fatal peritonitis caused by Rhizopus microsporus.
Topics: Antifungal Agents; Colon; Crohn Disease; Fatal Outcome; Female; Humans; Intestinal Perforation; Middle Aged; Mucormycosis; Peritonitis; Pyrimidines; Rhizopus; Triazoles; Voriconazole | 2010 |
Rhizopus oryzae skin infection treated with posaconazole in a boy with chronic granulomatous disease.
Topics: Antifungal Agents; Child, Preschool; Dermatomycoses; Granulomatous Disease, Chronic; Humans; Male; Mucormycosis; Rhizopus; Triazoles | 2010 |
Mucormycosis may mimic disease relapse in Wegener's granulomatosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Diagnosis, Differential; Drug Therapy, Combination; Granulomatosis with Polyangiitis; Humans; Immunocompromised Host; Male; Mucormycosis; Radiography, Thoracic; Recurrence; Treatment Outcome; Triazoles | 2010 |
Two new species of Mucor from clinical samples.
Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mucorales; Mucormycosis; Mycological Typing Techniques; Phylogeny; Sequence Analysis, DNA; Temperature; Triazoles; United States | 2011 |
Increasing incidence of mucormycosis in University Hospital, Belgium.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Belgium; Child; Female; Hematologic Neoplasms; Hospitals, University; Humans; Incidence; Male; Middle Aged; Mucormycosis; Pyrimidines; Risk Factors; Triazoles; Voriconazole; Young Adult | 2010 |
In vitro and in vivo antifungal susceptibilities of the Mucoralean fungus Cunninghamella.
Topics: Amphotericin B; Animals; Antifungal Agents; Caspofungin; Cunninghamella; Diabetes Mellitus, Experimental; Echinocandins; Itraconazole; Lipopeptides; Male; Mice; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2010 |
Sinonasal mucormycosis: case report.
Topics: Administration, Oral; Adult; Amphotericin B; Antifungal Agents; Combined Modality Therapy; Diabetes Complications; Diabetic Ketoacidosis; Endoscopy; Ethmoid Sinusitis; Humans; Infusions, Intravenous; Male; Mucormycosis; Opportunistic Infections; Rhinitis; Tomography, X-Ray Computed; Triazoles | 2010 |
Molecular phylogeny and proposal of two new species of the emerging pathogenic fungus Saksenaea.
Topics: Antifungal Agents; DNA, Fungal; DNA, Ribosomal Spacer; Environmental Microbiology; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mucorales; Mucormycosis; Mycological Typing Techniques; Naphthalenes; Peptide Elongation Factor 1; Phylogeny; Sequence Analysis, DNA; Spores, Fungal; Temperature; Terbinafine; Triazoles | 2010 |
Successful treatment of disseminated mixed invasive fungal infection after hematopoietic stem cell transplantation for severe aplastic anemia.
Topics: Anemia, Aplastic; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Combined Modality Therapy; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Mucormycosis; Rhizopus; Triazoles | 2012 |
Posaconazole cerebrospinal concentrations in an HIV-infected patient with brain mucormycosis.
Topics: Africa, Western; AIDS-Related Opportunistic Infections; Antifungal Agents; Brain; CD4 Lymphocyte Count; Central Nervous System Fungal Infections; Cerebrospinal Fluid; HIV Infections; Humans; Inhibitory Concentration 50; Magnetic Resonance Imaging; Mucormycosis; Radiography; Triazoles | 2011 |
Disseminated Rhizomucor pusillus causing early multiorgan failure during hematopoietic stem cell transplantation for severe aplastic anemia.
Topics: Amphotericin B; Anemia, Aplastic; Child; Female; Hematopoietic Stem Cell Transplantation; Humans; Mucormycosis; Multiple Organ Failure; Pyrimidines; Rhizomucor; Triazoles; Voriconazole | 2011 |
Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies: analysis of eight patients.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Biopsy; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Retrospective Studies; Survival Rate; Triazoles; Voriconazole | 2011 |
Cavitary lung lesions in a renal transplant recipient.
Topics: Amphotericin B; Antifungal Agents; Humans; Kidney Transplantation; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Radiography, Thoracic; Rhizopus; Triazoles | 2011 |
Failure of haematopoietic recovery overcome by SCT despite invasive mucormycosis infection.
Topics: Adult; Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Mucormycosis; Pyrimidines; Radiography; Remission Induction; Transplantation, Homologous; Triazoles; Voriconazole | 2012 |
Cerebral mucormycosis in a diabetic man.
Topics: Amphotericin B; Antifungal Agents; Biopsy; Brain Diseases; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diagnosis, Differential; Drug Therapy, Combination; Endoscopy; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mucormycosis; Tomography, X-Ray Computed; Triazoles | 2011 |
The reversed halo sign as the initial radiographic sign of pulmonary zygomycosis.
Topics: Amphotericin B; Antifungal Agents; Benzoates; Caspofungin; Deferasirox; Echinocandins; Fatal Outcome; Female; Humans; Iron Chelating Agents; Lipopeptides; Lung; Lung Diseases, Fungal; Middle Aged; Mucormycosis; Rhizopus; Stem Cell Transplantation; Tomography, X-Ray Computed; Triazoles | 2012 |
Rhinocerebral mucormycosis: a diagnostic challenge and therapeutic dilemma in immunocompetent host.
Topics: Adult; Amphotericin B; Antifungal Agents; Central Nervous System Fungal Infections; Eye Infections, Fungal; Female; Humans; Hyphae; Immunocompetence; Male; Maxilla; Middle Aged; Mucormycosis; Nose Diseases; Orbit; Paranasal Sinus Diseases; Pyrimidines; Triazoles; Voriconazole | 2012 |
Rhino-orbital-cerebral mucormycosis (ROCM): a comprehensive case review.
Topics: Adult; Amphotericin B; Antifungal Agents; Brain Diseases; Debridement; Diabetes Insipidus, Nephrogenic; Diabetes Mellitus, Type 1; Disease Progression; Eye Infections, Fungal; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Mucormycosis; Nose Diseases; Orbital Diseases; Tomography, X-Ray Computed; Triazoles | 2011 |
[Mucormycosis: retrospective evaluation of 12 cases].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Brain Diseases; Diabetes Complications; Female; Hematologic Diseases; Humans; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Nose Diseases; Orbital Diseases; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2011 |
A common fungus, an unusual (and deadly) infection.
Topics: Amphotericin B; Antifungal Agents; Biopsy; Debridement; Fatal Outcome; Female; Hemochromatosis; Hepatic Encephalopathy; Humans; Intubation, Gastrointestinal; Liver; Liver Failure, Acute; Middle Aged; Mucormycosis; Necrosis; Nose; Nose Diseases; Opportunistic Infections; Triazoles | 2011 |
Deferasirox in mucormycosis: hopefully, not defeated.
Topics: Amphotericin B; Animals; Antifungal Agents; Benzoates; Deferasirox; Female; Humans; Iron Chelating Agents; Male; Mucormycosis; Triazoles | 2012 |
Deferasirox as adjunctive therapy for mucormycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Benzoates; Deferasirox; Female; Humans; Iron Chelating Agents; Male; Mucormycosis; Triazoles | 2012 |
How does antifungal pharmacology differ for mucormycosis versus aspergillosis?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Cell Membrane; Cell Wall; Drug Resistance, Multiple, Fungal; Ergosterol; Gene Duplication; Genome, Fungal; Genomic Instability; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Rhizopus; Species Specificity; Triazoles; Virulence Factors; Voriconazole | 2012 |
Combination therapy for mucormycosis: why, what, and how?
Topics: Animals; Antifungal Agents; Benzoates; Clinical Trials as Topic; Deferasirox; Drug Therapy, Combination; Echinocandins; Humans; Lipids; Mice; Mucormycosis; Polyenes; Treatment Outcome; Triazoles | 2012 |
Future directions in mucormycosis research.
Topics: Antifungal Agents; Aspergillus; Biomedical Research; Early Diagnosis; Genome, Fungal; Humans; Immunocompromised Host; Mucormycosis; Pyrimidines; Rhizopus; Risk Factors; Triazoles; Voriconazole | 2012 |
In vitro and in vivo activities of posaconazole and amphotericin B in a murine invasive infection by Mucor circinelloides: poor efficacy of posaconazole.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Disease Models, Animal; Drug Resistance, Fungal; Kidney; Male; Mice; Microbial Sensitivity Tests; Mucor; Mucormycosis; Neutropenia; Species Specificity; Survival Rate; Treatment Failure; Triazoles | 2012 |
Efficacy of posaconazole in a murine model of disseminated infection caused by Apophysomyces variabilis.
Topics: Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Humans; Injections, Intravenous; Male; Mice; Microbial Sensitivity Tests; Mucorales; Mucormycosis; Treatment Outcome; Triazoles | 2012 |
Experimental murine model of disseminated infection by Saksenaea vasiformis: successful treatment with posaconazole.
Topics: Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Male; Mice; Microbial Sensitivity Tests; Mucorales; Mucormycosis; Treatment Outcome; Triazoles | 2012 |
Renal mucormycosis complicating extracorporeal membrane oxygenation.
Topics: Acute Kidney Injury; Aged; Amphotericin B; Antifungal Agents; Cross Infection; Extracorporeal Membrane Oxygenation; Female; France; Heart Failure; Humans; Immunocompromised Host; Kidney; Mucormycosis; Rheumatic Fever; Rhizopus; Treatment Outcome; Triazoles; Tuberculosis, Pulmonary | 2013 |
Rare pediatric rhino-orbital infection caused by Saksenaea vasiformis.
Topics: Amphotericin B; Antifungal Agents; Debridement; Humans; Infant; Male; Mucorales; Mucormycosis; Orbital Diseases; Paranasal Sinus Diseases; Tomography, X-Ray Computed; Treatment Outcome; Triazoles | 2012 |
Invasive mucormycosis in an immunocompetent patient with allergic fungal rhinosinusitis.
Topics: Antifungal Agents; Biopsy, Needle; Endoscopy; Follow-Up Studies; Fungemia; Humans; Immunocompetence; Immunohistochemistry; Male; Middle Aged; Mucorales; Mucormycosis; Rhinitis, Allergic, Perennial; Risk Assessment; Sinusitis; Treatment Outcome; Triazoles | 2013 |
Case report of hepatic mucormycosis after liver transplantation: successful treatment with liposomal amphotericin B followed by posaconazole sequential therapy.
Topics: Amphotericin B; Antifungal Agents; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Mucormycosis; Time Factors; Treatment Outcome; Triazoles; Young Adult | 2012 |
The surgical management of rhinocerebral mucormycosis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Brain Diseases; Cause of Death; Combined Modality Therapy; Diagnosis, Differential; Fatal Outcome; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Maxillary Sinusitis; Middle Aged; Mucormycosis; Nose Diseases; Paranasal Sinus Diseases; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2013 |
Pulmonary mucormycosis: what is the best strategy for therapy?
Topics: Acute Kidney Injury; Adult; Amphotericin B; Antifungal Agents; Debridement; Echinocandins; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Micafungin; Mucormycosis; Pneumonectomy; Triazoles | 2013 |
A non-fatal case of invasive zygomycete (Lichtheimia corymbifera) infection in an allogeneic haematopoietic cell transplant recipient.
Topics: Antifungal Agents; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Magnetic Resonance Imaging; Male; Middle Aged; Mucorales; Mucormycosis; Peripheral Blood Stem Cell Transplantation; Triazoles; Vidarabine | 2013 |
Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosis.
Topics: Animals; Antifungal Agents; Disease Models, Animal; Drosophila; Drug Synergism; Drug Therapy, Combination; Female; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mucormycosis; Rhizopus; Tacrolimus; Treatment Outcome; Triazoles | 2013 |
Successful treatment of pulmonary rhizopus infection with surgical resection and posaconazole in a renal transplant recipient.
Topics: Antifungal Agents; Combined Modality Therapy; Humans; Kidney Transplantation; Male; Middle Aged; Mucormycosis; Postoperative Complications; Remission Induction; Rhizopus; Triazoles | 2013 |
Concurrent pulmonary Aspergillus fumigatus and mucor infection in a cardiac transplant recipient: a case report.
Topics: Air Microbiology; Antifungal Agents; Cardiomyopathy, Dilated; Cyclonic Storms; Environmental Exposure; Heart Transplantation; Humans; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Mucormycosis; Pyrimidines; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Liposomal amphotericin B and surgery as successful therapy for pulmonary Lichtheimia corymbifera zygomycosis in a pediatric patient with acute promyelocytic leukemia on antifungal prophylaxis with posaconazole.
Topics: Absidia; Adolescent; Amphotericin B; Antifungal Agents; Female; Humans; Immunocompromised Host; Leukemia, Promyelocytic, Acute; Lung Diseases, Fungal; Mucormycosis; Pneumonectomy; Triazoles | 2013 |
Reflections on the approach to treatment of a mycologic disaster.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Cladosporium; Humans; Mucormycosis; Mycoses; Pyrimidines; Rhizopus; Rhodotorula; Triazoles; Voriconazole | 2013 |
Mucormycosis (zygomycosis) in a heart-kidney transplant recipient: recovery after posaconazole therapy.
Topics: Antifungal Agents; Diabetes Complications; Heart Transplantation; Humans; Immunosuppression Therapy; Kidney Transplantation; Male; Middle Aged; Mucormycosis; Postoperative Complications; Triazoles | 2003 |
[Fulminant invasive fungal sinusitis in immunosuppressed hosts -- pathognomic presentation in MRI].
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Ethmoid Sinusitis; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Mucor; Mucormycosis; Triazoles | 2004 |
Disseminated mucormycosis associated with invasive pulmonary aspergillosis in a patient treated for post-transplant high-grade non-Hodgkin's lymphoma.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis, Allergic Bronchopulmonary; Caspofungin; Echinocandins; Fatal Outcome; Female; Humans; Kidney Transplantation; Lipopeptides; Lymphoma, Non-Hodgkin; Middle Aged; Mucormycosis; Peptides, Cyclic; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2004 |
Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required.
Topics: Absidia; Adult; Antifungal Agents; Child, Preschool; Female; Hematologic Diseases; Humans; Immunocompromised Host; Male; Middle Aged; Mucormycosis; Pyrimidines; Rhizomucor; Rhizopus; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Breakthrough zygomycosis during empirical voriconazole therapy in febrile patients with neutropenia.
Topics: Aged; Antifungal Agents; Fever; Humans; Mucormycosis; Neutropenia; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2005 |
Pulmonary mucormycosis (zygomycosis) in a lung transplant recipient: recovery after posaconazole therapy.
Topics: Absidia; Antifungal Agents; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Bronchoscopy; Fatal Outcome; Female; Follow-Up Studies; Humans; Lung Diseases, Fungal; Lung Transplantation; Middle Aged; Mucormycosis; Pulmonary Fibrosis; Tomography, X-Ray Computed; Triazoles | 2005 |
Absidia posttraumatic infection: successful treatment with posaconazole.
Topics: Absidia; Antifungal Agents; Facial Injuries; Humans; Male; Mandibular Injuries; Middle Aged; Mucormycosis; Orbital Fractures; Treatment Outcome; Triazoles | 2005 |
Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Communicable Diseases, Emerging; Dermatomycoses; Disease Susceptibility; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Sinusitis; Transplantation Conditioning; Triazoles; Viscera; Voriconazole | 2005 |
Pulmonary mucormycosis (zygomycosis) in a lung transplant recipient: recovery after posaconazole therapy.
Topics: Absidia; Antifungal Agents; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Bronchoscopy; Fatal Outcome; Female; Follow-Up Studies; Humans; Lung Diseases, Fungal; Lung Transplantation; Middle Aged; Mucormycosis; Pulmonary Fibrosis; Tomography, X-Ray Computed; Triazoles | 2005 |
Periorbital zygomycosis (mucormycosis) treated with posaconazole.
Topics: Adult; Antifungal Agents; Antineoplastic Agents; Eye Infections, Fungal; Humans; Male; Microbial Sensitivity Tests; Mucormycosis; Orbital Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rhizopus; Tomography, X-Ray Computed; Triazoles | 2006 |
Successful use of posaconazole in a pediatric case of fungal necrotizing fasciitis.
Topics: Amphotericin B; Antifungal Agents; Child; Drug Therapy, Combination; Fasciitis, Necrotizing; Female; Humans; Mucormycosis; Mycoses; Triazoles; Trichosporon | 2006 |
Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Humans; Leukemia, Myeloid, Acute; Liposomes; Middle Aged; Mucormycosis; Rhizomucor; Treatment Outcome; Triazoles | 2006 |
Posaconazole for treatment of refractory invasive fungal disease.
Topics: Antifungal Agents; Aspergillosis; Aspergillus nidulans; Central Nervous System Fungal Infections; Child; Child, Preschool; Diabetes Mellitus, Type 1; Drug Resistance, Fungal; Female; Granulomatous Disease, Chronic; Humans; Immunocompromised Host; Lung Diseases, Fungal; Male; Mucormycosis; Rhizopus; Sinusitis; Treatment Outcome; Triazoles | 2006 |
Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Benzoates; Brain Stem; Caspofungin; Cavernous Sinus; Central Nervous System Fungal Infections; Deferasirox; Diabetic Ketoacidosis; Drug Therapy, Combination; Echinocandins; Humans; Iron Chelating Agents; Lipopeptides; Magnetic Resonance Imaging; Male; Mucormycosis; Nose Diseases; Peptides, Cyclic; Salvage Therapy; Triazoles | 2006 |
Posaconazole prophylaxis in experimental systemic zygomycosis.
Topics: Absidia; Amphotericin B; Animals; Antibiotic Prophylaxis; Antifungal Agents; Brain; Cells, Cultured; Disease Models, Animal; Kidney; Lung; Male; Mice; Microbial Sensitivity Tests; Mucormycosis; Rhizopus; Spleen; Time Factors; Triazoles | 2007 |
Early fatal Rhizopus infection on voriconazole prophylaxis following allogeneic stem cell transplantation.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mucormycosis; Pyrimidines; Rhizopus; Transplantation, Homologous; Triazoles; Voriconazole | 2007 |
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Mucormycosis in patients with complicated cirrhosis.
Topics: Antifungal Agents; Humans; Liver Cirrhosis; Mucormycosis; Triazoles | 2007 |
Successful treatment and limb salvage of mucor necrotizing fasciitis after kidney transplantation with posaconazole.
Topics: Alcaligenes; Amphotericin B; Amputation, Surgical; Antifungal Agents; Cefazolin; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Drug Resistance, Multiple, Fungal; Escherichia coli Infections; Fatal Outcome; Fluconazole; Gangrene; Graft Rejection; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leg; Leg Ulcer; Male; Middle Aged; Mucor; Mucormycosis; Penicillanic Acid; Phosphatidylcholines; Phosphatidylglycerols; Piperacillin; Postoperative Complications; Pyrimidines; Renal Dialysis; Reoperation; Sepsis; Skin Transplantation; Tazobactam; Triazoles; Voriconazole | 2007 |
Inherited long QT syndrome revealed by antifungals drug-drug interaction.
Topics: Acute Disease; Adolescent; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Female; Genotype; Humans; Injections, Intravenous; Leukemia, Myeloid; Long QT Syndrome; Mixed Function Oxygenases; Mucormycosis; Pyrimidines; Torsades de Pointes; Triazoles; Voriconazole | 2007 |
Rhino-orbital mucormycosis causing cavernous sinus and internal carotid thrombosis treated with posaconazole.
Topics: Antifungal Agents; Carotid Artery Thrombosis; Carotid Artery, Internal; Cavernous Sinus Thrombosis; Child; Debridement; Female; Humans; Magnetic Resonance Imaging; Mucor; Mucormycosis; Orbital Diseases; Paranasal Sinus Diseases; Triazoles | 2007 |
[Breakthrough pulmonary mucormycosis during voriconazole treatment after reduced-intensity cord blood transplantation for a patient with acute myeloid leukemia].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cord Blood Stem Cell Transplantation; Echinocandins; Fatal Outcome; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Mucormycosis; Peptides, Cyclic; Pyrimidines; Transplantation Conditioning; Triazoles; Voriconazole | 2007 |
Pulmonary mucormycosis in a nondiabetic renal allograft recipient successfully managed by medical therapy alone.
Topics: Antifungal Agents; Humans; Kidney Transplantation; Lung Diseases, Fungal; Male; Middle Aged; Mucorales; Mucormycosis; Postoperative Complications; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Early use of posaconazole in the successful treatment of rhino-orbital mucormycosis caused by Rhizopus oryzae.
Topics: Aged; Antifungal Agents; Ethmoid Sinusitis; Female; Humans; Male; Maxillary Sinusitis; Middle Aged; Mucormycosis; Rhizopus; Treatment Outcome; Triazoles | 2007 |
The iron chelator deferasirox protects mice from mucormycosis through iron starvation.
Topics: Amphotericin B; Animals; Benzoates; Deferasirox; Diabetes Mellitus; Drug Therapy, Combination; Iron; Iron Chelating Agents; Liposomes; Male; Mice; Mice, Inbred BALB C; Mucorales; Mucormycosis; Survival Rate; Th1 Cells; Th2 Cells; Triazoles | 2007 |
[Invasive zygomycosis in patients treated for haematological malignancies].
Topics: Adolescent; Amphotericin B; Antifungal Agents; Child, Preschool; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Mucormycosis; Organ Transplantation; Rhizopus; Transplantation Immunology; Triazoles; Zygomycosis | 2007 |
Simultaneous mold infections in an orthotopic heart transplant recipient.
Topics: Amphotericin B; Antibodies, Monoclonal; Antifungal Agents; Aspergillus fumigatus; Basiliximab; Cardiomyopathy, Dilated; Debridement; Dermatomycoses; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Mucormycosis; Prosthesis-Related Infections; Pulmonary Aspergillosis; Pyrimidines; Recombinant Fusion Proteins; Rhizopus; Triazoles; Voriconazole | 2008 |
Mucormycoses: serious complication of high-dose corticosteroid therapy for traumatic optic neuropathy.
Topics: Abscess; Antifungal Agents; Glucocorticoids; Humans; Jaw Fractures; Male; Methylprednisolone; Middle Aged; Mucormycosis; Optic Nerve Diseases; Retrobulbar Hemorrhage; Streptococcal Infections; Triazoles | 2008 |
Absidia corymbifera necrotizing cellulitis in an immunocompromised patient while on voriconazole treatment.
Topics: Absidia; Aged; Antifungal Agents; Diabetes Complications; Foot Injuries; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Mucormycosis; Pyrimidines; Triazoles; Voriconazole | 2008 |
Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro.
Topics: Absidia; Amphotericin B; Antifungal Agents; Cunninghamella; Drug Synergism; Humans; Hyphae; Microbial Sensitivity Tests; Mucor; Mucorales; Mucormycosis; Rhizomucor; Rhizopus; Spores, Fungal; Triazoles | 2008 |
Treatment of murine pulmonary mucormycosis with SCH 42427, a broad-spectrum triazole antifungal drug.
Topics: Amphotericin B; Animals; Antifungal Agents; Lung Diseases, Fungal; Mice; Mice, Inbred ICR; Mucormycosis; Triazoles | 1994 |
In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model.
Topics: Animals; Antifungal Agents; Immunocompromised Host; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mucor; Mucormycosis; Triazoles | 2002 |
Treatment of experimental zygomycosis in guinea pigs with azoles and with amphotericin B.
Topics: Amphotericin B; Animals; Antifungal Agents; Azoles; Fluconazole; Guinea Pigs; Itraconazole; Ketoconazole; Male; Mucormycosis; Rhizopus; Triazoles | 1989 |